Paralytic ileus and intestinal obstruction

K11_ILEUS

intestinal pseudo-obstruction: A type of ILEUS, a functional not mechanical obstruction of the INTESTINES. This syndrome is caused by a large number of disorders involving the smooth muscles (MUSCLE, SMOOTH) or the NERVOUS SYSTEM.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — K56 Cause of death: ICD-10 — K56 2 out of 7 registries used, show all original rules.	10778
4. Check minimum number of events None	10778
5. Include endpoints K11_PARALIL K11_INTUSS K11_VOLVU K11_IMPACT K11_ADHE K11_OTHILEUS	12102
6. Filter based on genotype QC (FinnGen only)	12102

Control definitions (FinnGen only)

Control exclude: K11_INTESTOTH

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: K55-K63
Name in latin: Ileus paralyticus sive obstructio intestini sine hernia

NAME	K11_ILEUS
CONTROL_EXCLUDE	K11_INTESTOTH
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	K11_PARALIL\|K11_INTUSS\|K11_VOLVU\|K11_IMPACT\|K11_ADHE\|K11_OTHILEUS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K56
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	K56
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Paralytic ileus and intestinal obstruction based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	110373	57288	51704
Only index persons	81601	43380	38221
Unadjusted period prevalence (%)
Whole population	1.55	1.64	1.44
Only index persons	1.53	1.59	1.46
Median age at first event (years)
Whole population	67.25	68.25	66.07
Only index persons	65.10	65.75	64.37

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	12102	5986	6116
Unadjusted period prevalence (%)	2.37	2.04	2.70
Median age at first event (years)	62.81	59.41	66.14

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
10776: Matched controls
107722

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

5.4

323.0

5647

18253

JFB30

NOMESCO Finland

Right hemicolectomy

15.3

323.0

558

382

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

50.6

323.0

706

149

JAH01

NOMESCO Finland

Laparoscopy

7.5

323.0

914

1315

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

3.4

323.0

2205

7669

JFK10

NOMESCO Finland

Freeing of adhesions in intestinal obstruction

332.5

323.0

412

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

5.1

323.0

1415

3115

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

29.7

323.0

722

260

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

102.5

323.0

1227

135

JN3BD

NOMESCO Finland

Extensive abdominal CT

10.9

323.0

3095

3830

TPH07

NOMESCO Finland

Cathetrisation of artery

3.5

323.0

1714

5486

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

7.5

323.0

861

1230

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

18.9

323.0

2033

1306

K56.7

ICD-10 Finland

Ileus, unspecified

3373.2

323.0

2258

A03FA01

ATC

metoclopramide; systemic, rectal

2.9

323.0

2960

12494

K59.0

ICD-10 Finland

Constipation

10.0

323.0

1025

1123

A06AC01

ATC

ispaghula (psylla seeds); oral

3.0

323.0

2918

12002

B01AB05

ATC

enoxaparin; parenteral

2.4

323.0

3915

20504

A06AD11

ATC

lactulose; oral

3.5

323.0

2452

8381

K56.0

ICD-10 Finland

Paralytic ileus

4454.2

323.0

1223

K56.1

ICD-10 Finland

Intussusception

6321.0

323.0

608

WX302

NOMESCO Finland

Thoracal epidural anesthesy

9.7

323.0

1601

1905

K56.2

ICD-10 Finland

Volvulus

8058.0

323.0

761

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

15.8

323.0

1900

1443

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

4326.1

323.0

5158

K59.09

ICD-10 Finland

Constipation, unspecified

14.8

323.0

1223

924

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.3

323.0

3952

16011

JAH00

NOMESCO Finland

Laparotomy

30.8

323.0

1569

592

WX408

NOMESCO Finland

General anesthesy, balanced

3.0

323.0

3720

16201

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

9.0

323.0

1784

2324

UJF30

NOMESCO Finland

Ileoscopy through colon

5.2

323.0

1130

2384

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

8224.2

323.0

2575

JFB00

NOMESCO Finland

Partial resection of small intestine

56.4

323.0

1101

217

5608A

ICD-9 Finland

Intestinal obstruction without mention of hernia, Other specified intestinal obstruction[OBSTRUCTIO INTESTINALIS ,ADHESIONES INTRAABDOMINALE]

+∞

323.0

437

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

8.1

323.0

1107

1498

JN3AD

NOMESCO Finland

Abdominal CT examination

9.5

323.0

2098

2667

TPH04

NOMESCO Finland

Cathetrisation of vein

2.9

323.0

2965

12390

UJF32

NOMESCO Finland

Coloscopy

7.0

323.0

4333

9384

P01AB01

ATC

metronidazole; oral, rectal

2.5

323.0

4306

22601

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

4.9

320.9

1149

2573

A02BC02

ATC

pantoprazole; systemic

2.2

320.1

7108

50336

130

Kela drug reimbursment

Malignant tumour

3.7

315.9

1568

4767

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

3.0

311.8

2164

8418

5609X

ICD-9 Finland

Intestinal obstruction without mention of hernia, Unspecified intestinal obstruction

+∞

310.8

297

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

1561.4

306.3

297

N02AX02

ATC

tramadol; systemic, rectal

2.2

302.6

4903

29875

JN4BD

NOMESCO Finland

Extensive body CT

3.3

300.9

1740

5941

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.2

299.7

1861

6690

R10.0

ICD-10 Finland

Acute abdomen

9.1

299.3

659

763

JFK00

NOMESCO Finland

Division of adhesive band in intestinal obstruction

492.4

290.7

289

A07EC02

ATC

mesalazine; oral, rectal

5.9

289.7

869

1580

R11

ICD-10 Finland

Nausea and vomiting

4.1

285.7

1244

3358

N02AA05

ATC

oxycodone; systemic

2.8

285.4

2186

8998

K50.0

ICD-10 Finland

Crohn disease of small intestine

20.3

281.1

431

221

J01MA02

ATC

ciprofloxacin; systemic

2.1

280.2

4539

27355

L01BC06

ATC

capecitabine; oral

6.2

280.2

809

1400

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

7.8

277.2

671

905

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.1

268.7

4999

31759

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

30.5

265.0

360

122

JFF10

NOMESCO Finland

Loop enterostomy

43.4

262.6

329

56096

ICD-8 Finland

Intestinal obstruction without mention of hernia, Ileus propter adhaesionem (functione laesa circulationis intestinalis non indicata)

+∞

258.3

247

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.6

255.1

2145

9261

JGC01

NOMESCO Finland

Laparoscopic rectopexy

122.1

253.5

274

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

11.8

252.7

484

429

N02BE01

ATC

paracetamol; systemic, rectal

2.4

249.5

9102

75187

K50.9

ICD-10 Finland

Crohn disease, unspecified

16.4

246.9

408

257

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

3.2

241.4

1460

5089

JFB46

NOMESCO Finland

Resection of sigmoid colon

19.4

241.1

375

200

K50.8

ICD-10 Finland

Other Crohn disease

16.0

238.2

398

258

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.3

227.9

1312

4402

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

8.4

226.1

522

650

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.7

225.8

1818

7594

K57.2

ICD-10 Finland

Diverticular disease of large intestine with perforation and abscess

75.3

224.8

257

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

7.2

220.4

562

815

45599

ICD-8 Finland

Haemorrhoids

+∞

219.4

210

K59.01

ICD-10 Finland

Constipation outlet obstruction type

548.7

217.9

216

N03AX16

ATC

pregabalin; oral

2.2

217.3

2627

13538

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

7.7

216.6

529

719

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.4

210.1

2142

10136

D01

ICPC

Abdominal pain/cramps general

3.3

205.0

1125

3627

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

32.4

203.6

272

L04AX01

ATC

azathioprine; systemic

4.9

201.8

704

1509

JFF23

NOMESCO Finland

Transversostomy

15.1

197.7

337

229

A07EA06

ATC

budesonide; oral, local oral

6.5

196.0

535

852

JN4AD

NOMESCO Finland

Body CT examination

3.2

191.9

1116

3744

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

13.6

191.7

342

259

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.7

189.7

1500

6145

6561

FHL

Removal of fasteners and related measures

50.8

188.5

229

K51.5

ICD-10 Finland

Left sided colitis

7.5

187.8

465

644

UJG02

NOMESCO Finland

Proctoscopy

9.8

187.0

392

412

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

37.3

186.5

241

TJF80

NOMESCO Finland

Ostomy education

15.2

185.2

315

213

ZX120

NOMESCO Finland

Intravenous

2.9

184.2

1279

4834

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

64.4

184.1

215

J01MA12

ATC

levofloxacin; systemic

2.2

183.5

2218

11302

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

5.2

183.1

606

1223

C10AC01

ATC

colestyramine; oral

7.7

180.6

439

591

K65.0

ICD-10 Finland

Acute peritonitis

13.2

179.6

325

254

JFB20

NOMESCO Finland

Ileocaecal resection

32.1

178.6

239

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

6.8

177.9

472

722

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

4.8

176.3

622

1345

K57.9

ICD-10 Finland

Diverticular disease of intestine, part unspecified, without perforation or abscess

31.7

175.8

236

Z93.3

ICD-10 Finland

Colostomy status

21.3

175.6

264

127

WX402

NOMESCO Finland

General anaesthesia

2.3

175.3

1806

8505

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.1

174.8

1048

3582

J01DB01

ATC

cefalexin; oral

1.9

173.7

8156

67169

K59.1

ICD-10 Finland

Functional diarrhoea

5.4

170.9

545

1053

K50.1

ICD-10 Finland

Crohn disease of large intestine

15.2

170.8

290

195

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

37.3

167.3

216

Z93.2

ICD-10 Finland

Ileostomy status

59.5

163.3

193

K55.0

ICD-10 Finland

Acute vascular disorders of intestine

1657.6

162.8

158

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

4.0

162.6

704

1856

JEA00

NOMESCO Finland

Appendectomy

3.5

162.4

817

2445

B01AB10

ATC

tinzaparin; parenteral

3.1

159.2

967

3326

JF1BD

NOMESCO Finland

Very extensive small bowel CT

27.5

158.8

221

JFB60

NOMESCO Finland

Resection of sigmoid colon with end colostomy

55.9

156.6

187

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

12.2

154.7

289

242

A02BC01

ATC

omeprazole; systemic

1.9

153.8

3024

18513

K60.3

ICD-10 Finland

Anal fistula

179.2

152.0

159

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.8

150.9

3288

20824

JFA70

NOMESCO Finland

Suture of small intestine

56.5

149.4

178

JF1AD

NOMESCO Finland

Small bowel CT

30.5

148.5

201

A02BC05

ATC

esomeprazole; systemic

1.8

146.6

3970

26910

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.8

146.6

1052

4027

TPX10

NOMESCO Finland

Implantation of vascular injection port

5.0

145.8

501

1050

JWA00

NOMESCO Finland

Repair of wound dehiscence in gastroenterological surgery

25.4

145.5

207

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.3

144.6

1520

7166

A04AA01

ATC

ondansetron; systemic, rectal

3.1

144.4

879

3019

R15

ICD-10 Finland

Faecal incontinence

6.5

143.1

392

625

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

14.6

142.6

246

172

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.0

140.5

872

3035

6453

FHL

Radical surgery of hemorrhoids

110.8

140.4

153

R50.9

ICD-10 Finland

Fever, unspecified

2.3

139.9

1531

7349

56099

ICD-8 Finland

Intestinal obstruction without mention of hernia, Other and unspecified

+∞

138.8

133

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.8

138.2

2868

17760

A04AA02

ATC

granisetron; systemic, transdermal

3.1

136.8

832

2853

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

4.9

136.6

475

1008

S18

ICPC

Laceration/cut

1.7

136.1

4250

29863

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

13.8

135.2

239

177

UJH02

NOMESCO Finland

Anoscopy

5.5

135.1

421

789

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

134.0

3505

23332

K92.1

ICD-10 Finland

Melaena

3.6

133.6

651

1891

N05CF01

ATC

zopiclone; oral

1.7

132.9

3479

23153

A07EA02

ATC

hydrocortisone; rectal

6.5

132.6

363

578

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.0

132.4

2073

11567

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

4.1

131.9

553

1411

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

5.7

131.6

397

716

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

3.4

130.9

690

2132

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

7.0

130.1

335

490

Z51.5

ICD-10 Finland

Palliative care

2.8

128.7

894

3342

K51.8

ICD-10 Finland

Other ulcerative colitis

9.9

126.8

263

271

H02AB02

ATC

dexamethasone; systemic

2.3

126.1

1265

5802

JFG40

NOMESCO Finland

Revision of enterostomy or colostomy without laparotomy

44.8

124.9

155

A02BC03

ATC

lansoprazole; oral

1.8

124.3

2995

19338

K91.4

ICD-10 Finland

Colostomy and enterostomy malfunction

78.9

123.5

140

H02AB06

ATC

prednisolone; systemic

1.6

122.4

4679

34443

K62.3

ICD-10 Finland

Rectal prolapse

43.0

122.3

153

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.1

121.6

1553

7946

UKC02

NOMESCO Finland

Cystoscopy

2.0

121.5

1842

10108

SPAT1262

SPAT

Handing over of treatment supplies

1.9

121.3

2045

11685

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

7.7

121.0

293

391

JG1JB

NOMESCO Finland

Defekography with X-ray

23.5

119.8

174

D64.9

ICD-10 Finland

Anaemia, unspecified

2.3

119.8

1198

5474

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

7.5

119.6

293

398

B03BA03

ATC

hydroxocobalamin; parenteral

2.8

119.5

836

3133

K59.9

ICD-10 Finland

Functional intestinal disorder, unspecified

14.0

119.2

209

152

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

9.0

118.9

260

294

XF400

NOMESCO Finland

ECG with 12 standard connections

2.0

118.3

1876

10467

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.1

118.1

1514

7752

JFH10

NOMESCO Finland

Total colectomy and ileostomy

82.9

116.4

131

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

5.3

115.7

370

714

N06AX11

ATC

mirtazapine; oral

1.7

115.7

3002

19737

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.0

115.4

1752

9603

JKA20

NOMESCO Finland

Cholecystectomy

4.2

115.3

467

1153

C03CA01

ATC

furosemide; systemic

1.7

114.8

3460

23744

JFF13

NOMESCO Finland

Terminal enterostomy

54.6

112.8

135

56095

ICD-8 Finland

Intestinal obstruction without mention of hernia, Ileus propter adhaesionem, cum functione laesa circulationis intestinalis

+∞

112.7

108

WX892

NOMESCO Finland

Monitored bed care

2.6

112.3

910

3717

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

27.1

111.2

155

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

18.1

110.6

175

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

13.5

110.0

196

148

N03AX12

ATC

gabapentin; oral

2.0

109.0

1514

7994

K61.0

ICD-10 Finland

Anal abscess

39.9

108.7

138

WW500

NOMESCO Finland

Blood transfusion

3.5

108.6

548

1632

WX306

NOMESCO Finland

Lumbar epidural anesthesy

3.2

108.4

619

2023

SPAT1125

SPAT

Stoma care and guidance

5.7

107.7

325

586

WZC30

NOMESCO Finland

Teaching

2.1

107.0

1410

7281

A03FA02

ATC

cisapride; oral, rectal

2.5

106.4

927

3933

WX002

NOMESCO Finland

Sedation and analgesia

1.8

105.8

2001

11835

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.2

104.7

1155

5512

K56.4

ICD-10 Finland

Other impaction of intestine

1027.9

104.4

102

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

3.1

103.5

611

2044

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.2

103.4

572

1826

D12

ICPC

Constipation

4.2

102.3

408

992

WX704

NOMESCO Finland

Intubation

2.6

100.9

815

3315

WX882

NOMESCO Finland

High dependency care

4.2

100.7

405

992

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

6.2

99.2

280

464

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

99.0

2007

12120

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

5.3

98.3

313

601

N05BA04

ATC

oxazepam; oral

1.7

98.1

2398

15345

A02BA02

ATC

ranitidine; systemic

1.8

97.7

2058

12572

R53

ICD-10 Finland

Malaise and fatigue

1.8

97.6

2019

12263

128

Kela drug reimbursment

Cancers of female genital organs

5.5

97.6

300

553

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.0

97.4

1510

8287

JFA58

NOMESCO Finland

Endoscopic dilatation of colon

41.0

96.8

122

JFB43

NOMESCO Finland

Left hemicolectomy

14.8

96.6

165

113

JAL30

NOMESCO Finland

Omentectomy

7.2

96.5

243

344

R4110

NOMESCO Finland

Physiotherapy

1.7

95.9

2603

17156

UJF92

NOMESCO Finland

Capsular endoscopy

6.8

95.7

251

377

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

3.6

95.3

463

1337

JHA00

NOMESCO Finland

Anal or perianal incision

28.2

95.2

131

TKC20

NOMESCO Finland

Catheterisation of bladder

2.4

94.9

883

3872

A28

ICPC

Limited function/disability NOS

1.9

94.8

1734

10093

K43.0

ICD-10 Finland

Incisional hernia with obstruction, without gangrene

9.2

93.5

201

221

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.4

93.5

865

3777

N06AA09

ATC

amitriptyline; systemic

2.2

93.1

1046

5021

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

3.4

93.0

483

1469

JFH00

NOMESCO Finland

Total colectomy and ileorectal anastomosis

44.6

92.8

115

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

3.2

92.7

526

1707

N05AH04

ATC

quetiapine; oral

1.9

92.5

1470

8132

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

5.9

92.2

270

469

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.4

91.9

828

3567

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

4.5

91.9

340

768

JAD10

NOMESCO Finland

Repair of incisional hernia

10.3

90.8

184

182

K60.1

ICD-10 Finland

Chronic anal fissure

23.9

90.2

130

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.1

90.2

532

1776

SPAT1254

SPAT

Administration of medicine

1.9

90.0

1545

8784

A09AA02

ATC

multienzymes (lipase, protease etc.)

5.0

89.9

302

616

A41.9

ICD-10 Finland

Sepsis, unspecified

3.2

89.6

504

1627

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

3.3

88.7

470

1451

N06AB04

ATC

citalopram; systemic

1.7

87.6

2027

12698

N06AX21

ATC

duloxetine; oral

2.2

87.5

946

4455

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

4.4

87.4

336

788

R4190

NOMESCO Finland

Nutritional therapy

3.9

87.1

382

1012

WX110

NOMESCO Finland

Local anesthesy

1.5

86.9

6154

50717

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

6.7

86.4

229

349

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

86.2

3018

21173

6402

FHL

Small bowel resection

35.3

86.1

112

SPAT1263

SPAT

Sampling

1.5

85.9

3980

29855

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

3.3

85.8

468

1477

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

10.0

85.6

176

179

UJD02

NOMESCO Finland

Gastroscopy

3.0

85.5

538

1875

D99

ICPC

Disease digestive system other

8.3

84.9

194

237

N81.6

ICD-10 Finland

Rectocele

2.7

84.8

634

2459

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

6.2

84.6

238

393

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.2

84.3

963

4644

D18

ICPC

Change in faeces/bowel movements

5.2

84.0

273

537

R06.0

ICD-10 Finland

Dyspnoea

1.7

83.7

2369

15695

JF1DG

NOMESCO Finland

Small bowel very extensive MRI with with high intensity magnet

36.3

83.6

108

D06

ICPC

Abdominal pain localized other

2.6

83.6

678

2756

K57.1

ICD-10 Finland

Diverticular disease of small intestine without perforation or abscess

26.2

83.5

117

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

7.6

83.2

201

268

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

6.3

83.0

231

376

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.4

81.8

731

3128

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.9

81.7

530

1882

N05BA01

ATC

diazepam; systemic, rectal

1.9

81.0

1352

7585

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

8.4

80.9

184

223

R33

ICD-10 Finland

Retention of urine

2.2

80.9

930

4494

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

14.2

80.7

140

100

J01EA01

ATC

trimethoprim; systemic

1.6

80.6

2431

16361

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

11.7

80.2

152

132

B81

ICPC

Anaemia vit B12/folate deficiency

3.0

79.7

495

1710

A07DA03

ATC

loperamide; oral

3.2

79.6

454

1478

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

4.1

78.8

324

810

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

78.3

4127

31652

N05AA02

ATC

levomepromazine; systemic

3.0

78.3

485

1671

R51.80

ICD-10 Finland

Headache

2.0

78.2

1146

6120

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.0

78.2

1093

5732

N30.0

ICD-10 Finland

Acute cystitis

1.9

78.1

1307

7329

JFG20

NOMESCO Finland

Closure of enterostomy with resection of exteriorised loop

16.8

77.7

126

AA1AD

NOMESCO Finland

CT of head and brain

1.6

77.6

2392

16160

SPAT1153

SPAT

Removal of sutures

1.5

77.4

3099

22331

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

3.8

77.3

341

908

5621B

ICD-9 Finland

Diverticula of intestine, Colon[DIVERTICULITIS COLI SINE HAEMORRHAGIA]

+∞

77.1

K57.0

ICD-10 Finland

Diverticular disease of small intestine with perforation and abscess

119.4

76.9

JFK01

NOMESCO Finland

Laparoscopic division of adhesive band in intestinal obstruction

105.8

76.9

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.4

76.4

690

2967

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

2.6

76.2

603

2413

Z93

ICD-10 Finland

Artificial opening status

22.9

76.1

111

JFC00

NOMESCO Finland

Entero-enterostomy

41.6

75.8

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.4

75.6

672

2867

N05CD07

ATC

temazepam; oral

1.8

75.2

1423

8320

J01DA01

ATC

[U] cefalexin; systemic

1.5

74.9

5945

49401

JFB33

NOMESCO Finland

Other resection comprising small intestine and colon

38.3

74.5

SPAT1255

SPAT

Intravenous administration of medicine

2.4

74.4

709

3133

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

4.0

74.3

311

790

K91.2

ICD-10 Finland

Postsurgical malabsorption, not elsewhere classified

39.5

74.2

K66.0

ICD-10 Finland

Peritoneal adhesions

14.6

73.7

126

C05AA08

ATC

fluocortolone; rectal, topical

1.9

73.7

1238

6944

M54.5

ICD-10 Finland

Low back pain

1.6

73.4

2735

19327

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

4.8

73.3

253

532

K56.3

ICD-10 Finland

Gallstone ileus

722.9

73.2

K63.2

ICD-10 Finland

Fistula of intestine

+∞

73.0

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.5

72.8

630

2649

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

72.7

4364

34220

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.1

72.4

948

4834

A03CA02

ATC

clidinium and psycholeptics; oral

2.5

72.1

629

2657

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

2.7

72.0

509

1908

K92.0

ICD-10 Finland

Haematemesis

3.7

71.8

334

930

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.7

71.5

509

1913

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

9.8

71.0

147

152

A06AC51

ATC

ispaghula, combinations; systemic

3.0

70.7

441

1525

J02AC01

ATC

fluconazole; systemic

1.5

70.6

3179

23418

JFB47

NOMESCO Finland

Laparoscopic resection of sigmoid colon

10.0

69.5

142

143

6101

FHL

Exploratory laparotomy, includes possible biopases

12.3

69.5

128

105

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

2.5

69.3

593

2478

D75

ICPC

Malignant neoplasm colon/rectum

8.0

69.2

162

206

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

5.5

69.2

214

398

M79.6

ICD-10 Finland

Pain in limb

1.5

68.4

3065

22523

D94

ICPC

Chronic enteritis/ulcerative colitis

12.2

68.2

126

104

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

7.1

67.8

172

247

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

6.5

67.5

182

285

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.9

67.3

1062

5813

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

3.3

67.0

364

1144

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.7

67.0

1536

9510

56500

ICD-8 Finland

Anal fissure and fistula, Anal fissure

+∞

66.7

E86

ICD-10 Finland

Volume depletion

3.4

66.6

336

999

UJF02

NOMESCO Finland

Peroral enteroscopy

12.2

66.4

123

102

E0000UV

ATC

1.5

66.3

3459

26206

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.7

66.1

1652

10485

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.2

66.0

367

1173

JFB50

NOMESCO Finland

Other resection of colon

19.6

66.0

101

JFH30

NOMESCO Finland

Total colectomy, mucosal proctectomy and ileoanal anastomosis without ileostomy

26.5

66.0

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

3.3

65.7

357

1122

4556A

ICD-9 Finland

Haemorrhoids, Unspecified haemorrhoids without mention of complication

+∞

65.7

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

65.4

2404

16851

D11

ICPC

Diarrhoea

2.1

65.2

809

4026

SPAT1301

SPAT

No procedures

1.5

65.0

3018

22291

5608X

ICD-9 Finland

Intestinal obstruction without mention of hernia, Other specified intestinal obstruction[OBSTRUCTIO INTESTINALIS, MUU SYY]

+∞

64.6

LAF10

NOMESCO Finland

Bilateral salpingo-oophorectomy

3.1

64.1

375

1242

JN4CD

NOMESCO Finland

Very extensive body CT

2.6

64.1

482

1873

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.5

63.8

309

889

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

8.8

63.2

139

160

K62.2

ICD-10 Finland

Anal prolapse

72.6

63.1

5601A

ICD-9 Finland

Intestinal obstruction without mention of hernia, Paralytic ileus

+∞

62.5

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

62.5

1577

10019

L28

ICPC

Limited function/disability (L)

1.7

61.7

1569

9989

JHD00

NOMESCO Finland

Anal dilatation

26.2

61.6

5621A

ICD-9 Finland

Diverticula of intestine, Colon[DIVERTICULOSIS COLI]

+∞

61.5

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

61.3

2358

16663

N06AX16

ATC

venlafaxine; oral

1.9

61.3

1041

5840

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

4.8

61.0

213

454

H02AB07

ATC

prednisone; oral

1.7

60.8

1363

8360

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.5

60.8

519

2162

K62.4

ICD-10 Finland

Stenosis of anus and rectum

309.2

60.4

C20

ICD-10 Finland

Malignant neoplasm of rectum

6.8

60.3

156

231

56098

ICD-8 Finland

Intestinal obstruction without mention of hernia, Alii definiti

+∞

59.4

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.3

59.3

320

1001

LCD00

NOMESCO Finland

Hysterectomy

2.6

59.2

458

1808

E87.6

ICD-10 Finland

Hypokalaemia

3.0

59.1

362

1238

JF2AB

NOMESCO Finland

Colongraphy with X-ray

20.4

59.1

R03BB04

ATC

tiotropium bromide; inhalant

1.8

58.4

1053

6024

107

Kela drug reimbursment

Pernicious anaemia

3.4

58.2

298

896

JGB30

NOMESCO Finland

Abdominoperineal excision of rectum

13.8

57.8

101

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

57.4

1540

9929

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.7

57.4

407

1528

J01MA14

ATC

moxifloxacin; systemic

1.9

57.4

851

4539

R18

ICD-10 Finland

Ascites

3.8

57.3

252

670

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

6.3

57.1

156

249

WF001

NOMESCO Finland

Preoperative radiotherapy

6.3

56.7

155

248

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

56.6

1564

10162

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.4

56.6

214

495

UJK02

NOMESCO Finland

ERCP

3.2

56.5

313

998

JF2BD

NOMESCO Finland

Extensive colon CT

9.8

56.4

116

119

Z71.8

ICD-10 Finland

Other specified counselling

1.6

56.4

1925

13190

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

12.7

56.3

102

K59.3

ICD-10 Finland

Megacolon, not elsewhere classified

+∞

56.3

WX725

NOMESCO Finland

Noninvasive ventilation

2.5

56.1

478

1989

K30

ICD-10 Finland

Functional dyspepsia

1.9

56.1

830

4424

K62.8

ICD-10 Finland

Other specified diseases of anus and rectum

20.6

56.0

JHD20

NOMESCO Finland

Incision of fistula-in-ano

102.2

55.8

R52.2

ICD-10 Finland

Other chronic pain

3.1

55.4

316

1028

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

5.3

55.0

173

329

A04

ICPC

Weakness/tiredness general

1.8

55.0

1142

6831

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.2

54.9

594

2779

JFH33

NOMESCO Finland

Total colectomy, mucosal proctectomy, ileoanal anastomosis and ileostomy

100.5

54.8

56310

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Ulcerative colitis

10.8

54.7

107

100

N05AH02

ATC

clozapine; systemic

4.5

54.7

200

448

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.1

54.3

674

3348

JWW96

NOMESCO Finland

Other reoperation in gastroenterological surgery

24.2

54.0

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.6

53.5

1724

11635

N03AE01

ATC

clonazepam; systemic

2.3

53.4

534

2409

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.5

53.3

2251

16158

5650B

ICD-9 Finland

Anal fissure and fistula, Anal fissure[FISSURA ANI TYPICA]

+∞

53.1

5602C

ICD-9 Finland

Intestinal obstruction without mention of hernia, Volvulus[VOLVULUS INTESTINI TENUIS]

+∞

53.1

K91.3

ICD-10 Finland

Postoperative intestinal obstruction

49.5

53.0

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

3.3

52.9

278

853

6451

FHL

Dilatation

97.2

52.8

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

4.2

52.7

210

511

XJH10

NOMESCO Finland

Anorectal manometry

22.1

52.6

N05BA06

ATC

lorazepam; systemic, sublingual

2.2

52.5

546

2509

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.7

52.4

381

1451

R19.5

ICD-10 Finland

Other faecal abnormalities

5.5

52.3

159

291

JAL20

NOMESCO Finland

Excision or destruction of lesion of peritoneum

9.1

52.2

112

124

K45.8

ICD-10 Finland

Other specified abdominal hernia without obstruction or gangrene

9.4

52.2

110

118

JFC20

NOMESCO Finland

Other enterocolostomy

66.9

52.1

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

52.1

2759

20737

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.7

52.1

366

1365

56000

ICD-8 Finland

Intestinal obstruction without mention of hernia, Intussusception

+∞

52.1

6421

FHL

Appendicectomy

2.3

52.0

508

2263

WX610

NOMESCO Finland

Patient controlled analgesia

9.6

51.8

108

114

J01AA02

ATC

doxycycline; systemic

1.4

51.8

7413

66122

5562A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) proctitis

15.5

51.7

XJH00

NOMESCO Finland

Transanal ultrasonography

2.0

51.7

687

3507

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

51.6

1552

10280

1470

FHL

Rectoscopy

16.3

51.6

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

51.4

3028

23216

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

3.3

51.3

266

809

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

51.2

1314

8351

K57

ICD-10 Finland

Diverticular disease of intestine

6.2

51.0

141

229

WX872

NOMESCO Finland

Intensive care

2.3

50.8

521

2377

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.1

50.8

648

3257

N05AH03

ATC

olanzapine; systemic

2.3

50.6

496

2214

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

4.5

50.2

185

418

JWF00

NOMESCO Finland

Reoperation for insufficiency of anastomosis or suture in gastroenterological surgery

20.4

49.9

R03AC02

ATC

salbutamol; inhalant

1.4

49.8

4476

36889

JHW96

NOMESCO Finland

Other operation on anus or perianal tissue

29.3

49.6

LAF16

NOMESCO Finland

Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer

7.6

49.5

119

159

XF600

NOMESCO Finland

Bloodpressure measurement

2.1

49.3

615

3062

R13

ICD-10 Finland

Dysphagia

2.1

49.2

590

2888

JFA38

NOMESCO Finland

Endoscopic dilatation of small intestine

70.2

49.0

JFC10

NOMESCO Finland

Ileotransversostomy

49.4

48.9

D29

ICPC

Digestive symptom/complaint other

4.1

48.7

196

482

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.6

48.6

1270

8099

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.9

48.6

828

4635

T81.9

ICD-10 Finland

Unspecified complication of procedure

3.9

48.5

206

532

K61.1

ICD-10 Finland

Rectal abscess

479.8

48.4

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

48.4

3305

25966

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.3

48.3

254

781

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.9

48.2

747

4043

6419

FHL

Other measure in this category

27.6

48.1

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

5.5

48.0

145

264

D37.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Rectum

6.1

48.0

135

225

K55.9

ICD-10 Finland

Vascular disorder of intestine, unspecified

128.0

47.8

JH1CG

NOMESCO Finland

Extensive MRI of perianal area

29.2

47.4

D10

ICPC

Vomiting

2.5

47.2

376

1506

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

47.1

3811

30775

JFL10

NOMESCO Finland

Laparotomy and manipulation of obstructed intestine

+∞

46.9

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

3.3

46.9

251

782

JGC30

NOMESCO Finland

Excision and suture of rectal mucosa with imbrication of muscular layer

164.0

46.8

UJF34

NOMESCO Finland

Left colonoscopy

8.4

46.8

105

126

G04CA02

ATC

tamsulosin; oral

1.5

46.7

2279

16792

C17.2

ICD-10 Finland

Malignant neoplasm: Ileum

24.6

46.6

A06AH03

ATC

naloxegol; oral

5.0

46.3

153

309

K50

ICD-10 Finland

Crohn disease [regional enteritis]

15.6

46.0

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.8

46.0

915

5384

K62.0

ICD-10 Finland

Anal polyp

38.9

45.9

J01FF01

ATC

clindamycin; systemic

1.4

45.9

2315

17160

56020

ICD-8 Finland

Intestinal obstruction without mention of hernia, Volvulus

+∞

45.8

4550A

ICD-9 Finland

Haemorrhoids, Internal haemorrhoids without mention of complication

+∞

45.8

JFA00

NOMESCO Finland

Enterotomy

85.4

45.8

A01

ICPC

Pain general/multiple sites

2.0

45.8

650

3403

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.8

45.8

866

5014

G44.2

ICD-10 Finland

Tension-type headache

1.7

45.7

948

5651

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

4.0

45.5

189

479

K51

ICD-10 Finland

Ulcerative colitis

7.1

45.3

113

160

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.0

45.3

595

3021

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

7.6

45.3

108

143

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

2.0

45.2

620

3204

D02

ICPC

Abdominal pain epigastric

2.3

45.1

454

2053

WX600

NOMESCO Finland

Single shot through catheter

4.2

45.1

176

421

JFG50

NOMESCO Finland

Laparotomy with revision of enterostomy or colostomy

73.3

44.9

L04AB04

ATC

adalimumab; parenteral

4.0

44.9

186

470

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

3.2

44.9

249

796

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

3.5

44.9

216

620

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.9

44.9

710

3870

B01AB04

ATC

dalteparin; parenteral

2.1

44.7

506

2416

C07AB07

ATC

bisoprolol; oral

1.3

44.3

4616

38676

Z43.2

ICD-10 Finland

Attention to ileostomy

21.8

44.3

K83.0

ICD-10 Finland

Cholangitis

4.0

44.2

184

467

N03AG01

ATC

valproic acid; systemic, rectal

2.1

43.9

514

2489

M03BX02

ATC

tizanidine; oral

1.3

43.8

5112

43547

J01CA04

ATC

amoxicillin; systemic

1.3

43.8

7263

65235

5640A

ICD-9 Finland

Functional digestive disorders, not elsewhere classified, Constipation

+∞

43.8

K63.9

ICD-10 Finland

Disease of intestine, unspecified

27.4

43.7

N06AB03

ATC

fluoxetine; oral

1.7

43.6

1002

6154

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.9

43.5

652

3484

56300

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Regional enteritis

23.9

43.5

R60.0

ICD-10 Finland

Localized oedema

1.7

43.4

992

6081

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.0

43.4

551

2762

JAH33

NOMESCO Finland

Opening of laparostomy

28.2

43.3

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

43.3

1247

8143

Z51.4

ICD-10 Finland

Preparatory care for subsequent treatment, not elsewhere classified

6.1

43.0

120

198

N05AF03

ATC

chlorprothixene; systemic

3.0

43.0

256

860

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.7

43.0

874

5173

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

3.7

42.9

194

530

K51.2

ICD-10 Finland

Ulcerative (chronic) proctitis

4.9

42.6

143

294

N05CF02

ATC

zolpidem; oral

1.6

42.6

1401

9449

TK800

NOMESCO Finland

Hemodialysis

3.2

42.6

237

760

JFB40

NOMESCO Finland

Resection of transverse colon

19.2

42.5

N06AB06

ATC

sertraline; oral

1.8

42.3

784

4505

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.8

42.2

714

3979

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

42.2

1178

7626

JGB10

NOMESCO Finland

Partial proctectomy and end colostomy

17.9

42.2

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

42.1

982

6056

JFG36

NOMESCO Finland

Closure of terminal colostomy with anastomosis to rectum

147.2

41.8

SPAT1229

SPAT

Assessment of need for aid

1.8

41.8

776

4466

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

41.7

1716

12170

WX290

NOMESCO Finland

Other blockade of nerve

1.4

41.6

3194

25428

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

41.5

3425

27590

D17

ICPC

Incontinence of bowel

6.5

41.5

110

170

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.3

41.4

219

677

A01AB09

ATC

miconazole; local oral

1.8

41.3

789

4578

XKD00

NOMESCO Finland

Uroflowmetry

1.5

41.2

1514

10476

XX3DW

NOMESCO Finland

Time consuming IT work

1.7

41.1

927

5658

M01AH01

ATC

celecoxib; oral (coxibs)

1.5

41.0

1569

10950

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

3.2

40.9

219

683

K65.9

ICD-10 Finland

Peritonitis, unspecified

13.7

40.9

XX1XW

NOMESCO Finland

Extensive written report from radiologist

3.2

40.7

225

719

F20.9

ICD-10 Finland

Schizophrenia, unspecified

3.3

40.7

210

638

56010

ICD-8 Finland

Intestinal obstruction without mention of hernia, Paralytic ileus

+∞

40.6

L01BB02

ATC

mercaptopurine; oral

5.8

40.5

118

206

R35

ICD-10 Finland

Polyuria

2.0

40.4

560

2902

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

3.4

40.4

203

604

J01CA08

ATC

pivmecillinam; oral

1.4

40.2

3176

25375

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

2.8

39.9

273

1003

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.0

39.9

512

2575

J01FA06

ATC

roxithromycin; oral

1.3

39.9

3485

28273

K63.8

ICD-10 Finland

Other specified diseases of intestine

75.4

39.9

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

3.4

39.8

197

579

S97

ICPC

Chronic ulcer skin

2.0

39.7

534

2736

JGB96

NOMESCO Finland

Other proctectomy or excision of rectum

107.9

39.7

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

4.1

39.6

161

401

R42

ICD-10 Finland

Dizziness and giddiness

1.4

39.6

1900

13887

LX1XE

NOMESCO Finland

Other gynecological ultrasound examination

2.9

39.6

252

886

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.0

39.5

555

2894

N81.5

ICD-10 Finland

Vaginal enterocele

3.5

39.5

191

552

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

8.6

39.5

102

SPAT1167

SPAT

Insertion of urinary catheter

2.4

39.4

361

1560

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

3.0

39.2

235

795

SPAT1216

SPAT

Assessment of functional ability

1.5

39.1

1464

10161

WX730

NOMESCO Finland

Conventional respirator

3.4

39.0

199

599

N06AB10

ATC

escitalopram; oral

1.5

38.9

1400

9631

D50.8

ICD-10 Finland

Other iron deficiency anaemias

4.1

38.9

157

389

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.5

38.8

320

1308

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.3

38.8

371

1639

JFB96

NOMESCO Finland

Other partial excision of intestine

37.9

38.7

RD210

NOMESCO Finland

3.5

38.5

184

527

L01BC59

ATC

trifluridine, combinations; systemic

16.4

38.4

XX4AT

NOMESCO Finland

Other canalization with ultrasound guidance

10.3

38.3

5552A

ICD-9 Finland

Regional enteritis, Small intestine with large intestine

56.4

38.3

JFG30

NOMESCO Finland

Closure of colostomy with resection of exteriorised loop

42.8

38.1

JGB50

NOMESCO Finland

Mucosal proctectomy and ileoanal anastomosis

72.0

37.9

K59.8

ICD-10 Finland

Other specified functional intestinal disorders

17.2

37.9

K85

ICD-10 Finland

Acute pancreatitis

3.2

37.8

202

630

K29.7

ICD-10 Finland

Gastritis, unspecified

2.5

37.7

305

1236

T81.2

ICD-10 Finland

Accidental puncture and laceration during a procedure, not elsewhere classified

4.4

37.7

139

316

JX1LA

NOMESCO Finland

Kinetic X-ray of alimentary tract with pictures

26.1

37.5

C56.00

ICD-10 Finland

Malignant tumor of the ovary without histology

6.2

37.4

103

168

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.9

37.3

595

3251

C56

ICD-10 Finland

Malignant neoplasm of ovary

7.5

37.2

119

A07EC01

ATC

sulfasalazine; oral, rectal

1.8

37.2

678

3872

A07AA02

ATC

nystatin; oral

1.9

37.2

565

3031

6525

FHL

Enterostomy occlusion

41.9

37.1

121

Kela drug reimbursment

Severe hypofunction of sexual glands

3.3

37.1

194

596

R31

ICD-10 Finland

Unspecified haematuria

1.6

37.1

939

5917

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.6

37.1

1046

6780

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

5.1

37.1

120

238

K62.6

ICD-10 Finland

Ulcer of anus and rectum

9.7

37.0

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

5.8

37.0

107

186

K59.4

ICD-10 Finland

Anal spasm

30.7

36.9

E87.5

ICD-10 Finland

Hyperkalaemia

3.3

36.9

193

593

R06AE07

ATC

cetirizine; oral

1.3

36.9

3435

28061

SPAT1104

SPAT

Monitoring of emergency patient

1.9

36.8

591

3233

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

2.9

36.8

236

834

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.8

36.7

681

3910

K83.1

ICD-10 Finland

Obstruction of bile duct

3.9

36.7

157

410

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

4.8

36.7

125

262

D91

ICPC

Abdominal hernia other

4.4

36.5

135

308

JFF26

NOMESCO Finland

Sigmoidostomy

19.7

36.4

XKC03

NOMESCO Finland

Water cystometry

2.5

36.4

289

1160

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.8

36.3

641

3624

GD1AD

NOMESCO Finland

Thorax CT examination

2.2

36.3

397

1866

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

36.2

2477

19263

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

10.8

36.2

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

5324

33234

2.07

318.26

4.4

3.2

—

0.6

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

926

2439

4.03

308.97

1.5

1.2

—

(3048689) Calprotectin [Mass/mass] in Stool

1992

7135

3.14

307.65

3.6

2.0

ug/g

225.6

134.6

12.89

1678

5497

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

9388

70920

2.44

307.65

13.7

7.0

u/l

85.8

80.1

14.69

9098

66122

(3013650) Neutrophils [#/volume] in Blood by Automated count

7590

51088

2.30

307.65

15.0

8.6

e9/l

4.5

4.2

15.24

6848

44032

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2597

11936

2.50

307.65

7.0

5.3

mmol/l

1.0

0.07

2451

10996

(3024561) Albumin [Mass/volume] in Serum or Plasma

6814

40102

2.60

307.65

9.5

4.4

g/l

33.0

35.1

128.63

6485

36796

(3003396) Base excess in Arterial blood by calculation

2434

10768

2.58

307.65

9.3

6.6

mmol/l

1.2

1.1

0.53

1995

8371

(3002032) Base excess in Venous blood by calculation

2089

8514

2.76

307.65

5.2

3.7

mmol/l

2.2

1.9

2.12

1749

6874

(3027801) Oxygen [Partial pressure] in Arterial blood

2425

10787

2.56

307.65

9.2

6.6

kpa

12.8

12.1

6.69

2311

10246

(3021447) Carbon dioxide [Partial pressure] in Venous blood

2102

8577

2.75

307.65

5.1

3.6

kpa

5.8

0.22

2046

8305

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2305

9485

2.77

307.65

3.9

2.7

umol/l

8.7

9.6

1.04

2042

8216

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2174

7340

3.39

307.65

3.6

2.3

u/l

36.0

59.3

1.27

1943

6206

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

8139

46469

3.29

307.65

10.4

5.9

umol/l

11.2

12.0

6.73

7909

43837

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2425

10791

2.56

307.65

9.2

6.6

kpa

5.1

0.48

2311

10261

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

6948

47542

2.08

307.65

10.1

6.2

mmol/l

1.2

46.99

5942

39516

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2211

5683

4.53

307.65

2.1

1.5

—

(3000991) Gas panel - Venous blood

1928

7517

2.86

307.65

9.8

7.7

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

6120

26191

3.70

307.65

3.9

2.4

u/l

56.4

59.9

4.11

5866

23917

(3002173) Hemoglobin [Mass/volume] in Arterial blood

2099

8711

2.70

307.65

10.1

7.4

g/l

117.4

121.5

15.03

2033

8382

(3016502) Oxygen saturation in Arterial blood

2266

9558

2.69

307.65

9.6

7.0

95.9

95.5

1.98

2174

9185

(3032080) INR in Blood by Coagulation assay

6453

39179

2.38

307.65

11.0

9.6

inr

1.2

1.3

9.21

1943

11067

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2188

8151

3.05

307.65

2.9

2.1

g/l

0.2

1.81

2045

7507

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2759

9421

3.50

307.65

6.1

3.9

ug/l

14.8

25.2

2.24

2346

7733

(3014576) Chloride [Moles/volume] in Serum or Plasma

2876

11462

2.98

307.65

10.7

6.5

mmol/l

103.8

104.5

8.27

2819

11183

(3012544) pH of Venous blood

2154

8901

2.73

307.65

5.1

3.6

7.4

1.00

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

4073

21045

2.41

307.65

3.6

2.2

—

(3022145) Colonoscopy Study observation

2199

6966

3.63

307.65

1.7

1.3

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

7956

54527

2.34

307.65

7.7

4.4

mmol/l

6.8

1.01

7685

50928

(3044640) Blood type and Crossmatch panel - Blood

5279

27961

2.57

307.65

3.8

2.3

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

4144

22487

2.28

307.65

2.9

2.1

mg/l

3.2

3.0

5.45

3624

18961

(3012095) Magnesium [Moles/volume] in Serum or Plasma

3213

14756

2.60

307.65

5.1

3.1

mmol/l

0.8

10.97

3052

13610

(3023368) Bacteria identified in Blood by Culture

5332

25865

2.90

307.65

6.1

4.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

6882

41646

2.51

307.65

5.9

3.9

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

2212

7788

3.25

307.65

7.5

6.6

mmol/l

1.4

0.15

2146

7451

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1126

3094

3.91

307.65

4.7

3.4

u/ml

1114.1

2075.0

0.44

984

2659

(3042936) Bacteria identified in Isolate by Culture

2898

12507

2.73

307.65

2.6

1.9

—

(3031040) Bacteria [#/volume] in Urine by Automated count

8199

60425

2.10

304.49

6.6

4.3

e6/l

1943.5

1483.8

0.29

160

963

(3026008) Bacteria identified in Urine by Culture

4735

28689

2.07

303.07

4.3

3.0

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4584

27487

2.07

301.44

4.8

3.1

u/l

34.0

35.0

0.37

4349

25891

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

6356

43001

2.01

296.42

9.4

5.6

mmol/l

1.2

40.94

5885

38543

(3022948) Iron [Moles/volume] in Serum or Plasma

2800

13975

2.30

292.39

3.1

2.4

umol/l

11.3

12.8

20.90

2625

12848

(3020779) Urea [Moles/volume] in Serum or Plasma

1938

8249

2.61

287.05

8.5

6.6

mmol/l

10.3

10.5

0.43

1850

7789

(3026782) Osmolality of Urine

3348

18272

2.15

278.39

3.6

2.7

mosm/kgh2o

531.8

550.5

5.41

2971

15490

(3000850) Epithelial cells [#/volume] in Urine

3489

19383

2.12

276.71

3.3

2.5

e6/l

5.9

5.3

1.51

3149

16851

(3013115) Eosinophils [#/volume] in Blood

6548

45447

1.96

275.92

8.5

5.6

e9/l

0.2

5.29

5785

39245

(3006315) Basophils [#/volume] in Blood

6381

44062

1.95

271.21

8.1

5.5

e9/l

0.0

1.88

5610

37414

(3002582) Erythrocytes [#/volume] in Urine

4578

28255

2.00

270.62

4.4

3.1

e6/l

60.9

116.6

3.37

3796

21439

(3001604) Monocytes [#/volume] in Blood

6348

43835

1.94

268.94

8.1

5.5

e9/l

0.6

1.05

5575

37214

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2927

15379

2.19

266.45

2.2

1.8

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2587

12929

2.27

266.37

3.1

2.3

g/l

2.3

0.18

2416

11898

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2459

12111

2.29

261.69

3.1

2.4

19.9

22.6

15.74

2098

10216

(3019198) Lymphocytes [#/volume] in Blood

6456

45113

1.92

260.85

8.2

5.5

e9/l

1.8

1.9

7.69

5735

39044

(3019069) Monocytes/100 leukocytes in Blood

6041

41464

1.91

256.05

8.6

6.0

8.8

8.7

0.20

5719

38439

(3022096) Basophils/100 leukocytes in Blood

5871

40045

1.90

252.45

8.2

5.7

0.6

0.7

9.05

5551

36982

(3024354) Oxygen [Partial pressure] in Venous blood

1675

7042

2.60

252.30

4.2

3.1

kpa

4.7

4.5

2.65

1624

6790

(42870588) Differential panel, method unspecified - Blood

4740

30144

1.94

252.18

7.6

5.6

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

5343

35411

1.91

250.30

3.8

2.6

ug/l

145.8

150.2

0.36

4916

32256

(3006504) Eosinophils/100 leukocytes in Blood

5992

41244

1.90

249.47

8.2

5.7

2.6

2.9

16.56

5666

38060

(3002030) Lymphocytes/100 leukocytes in Blood

6119

42480

1.89

247.28

8.4

5.8

24.8

27.0

43.98

5772

39121

(3000570) Elastase.pancreatic [Mass/mass] in Stool

722

1887

4.00

242.38

1.5

1.4

ug/g

235.2

268.6

3.36

454

1134

(3033658) Prothrombin time (PT) actual/Normal

3833

22939

1.98

241.55

7.0

3.7

86.5

87.7

2.09

3755

22349

(3018010) Neutrophils/100 leukocytes in Blood

6016

41767

1.87

240.76

8.0

5.6

60.0

57.9

30.30

5681

38651

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1165

4168

2.98

238.50

5.3

4.0

mmol/l

24.3

24.2

0.43

1085

3701

(3030467) Casts [#/volume] in Urine by Automated count

4177

25838

1.94

238.12

4.3

3.0

e6/l

0.6

0.5

2.16

3398

19302

(3018095) Leukocytes [#/volume] in Urine

4941

32592

1.87

228.89

5.1

3.5

e6/l

141.8

114.7

1.04

3957

22978

(3014007) Fractional oxyhemoglobin in Arterial blood

1411

5712

2.66

228.23

11.0

8.6

94.2

93.8

1.41

1404

5684

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

5368

36426

1.85

226.44

4.8

3.6

ng/l

35.0

76.8

2.37

4179

26240

(36304419) Bacteria [Presence] in Urine

4012

24963

1.91

221.11

4.2

3.0

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1385

5721

2.60

214.40

11.1

8.5

0.7

4.70

1371

5676

(3025941) Bacteria identified in Stool by Culture

1082

3941

2.92

213.64

1.5

1.2

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1336

5447

2.63

212.29

8.0

6.9

mmol/l

25.1

24.8

1.77

1322

5385

(40768797) Stomach Pathology biopsy report

2107

10540

2.21

211.46

1.4

1.2

—

(3019060) Gas panel - Arterial blood

1472

6336

2.51

208.75

6.9

4.5

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1371

5756

2.56

204.75

11.1

8.4

1.3

1.4

1.69

1356

5713

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1228

4898

2.68

203.55

11.5

9.0

—

(3037467) Urinalysis macro (dipstick) panel - Urine

8013

62750

1.82

198.70

6.3

4.1

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1371

6022

2.44

184.90

10.5

6.6

mmol/l

24.7

24.6

0.14

1294

5589

(40758558) Short blood count panel - Blood

3554

22348

1.83

182.21

11.3

6.6

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2035

10629

2.10

180.17

2.1

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2033

10651

2.09

178.38

2.1

1.7

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1240

5356

2.46

172.95

1.7

1.5

—

(3007853) Bacteria identified in Skin by Aerobe culture

1970

10426

2.06

167.24

2.2

1.8

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

968

3811

2.67

163.40

2.3

1.9

ug/l

2.8

2.4

0.42

864

3326

(3018418) pH of Serum or Plasma

4177

28302

1.73

161.46

5.5

3.9

7.4

2.77

891

5555

(3027945) Reticulocytes/100 erythrocytes in Blood

1986

10668

2.03

161.33

2.6

2.4

1.8

1.76

1734

9354

(3015377) Calcium [Moles/volume] in Serum or Plasma

4554

31634

1.70

160.39

4.9

3.3

mmol/l

2.3

2.4

23.51

4068

27257

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

608

1863

3.38

160.21

4.7

3.2

u/ml

323.2

1043.4

1.21

563

1711

(3004119) Hemoglobin [Mass/volume] in Venous blood

1244

5630

2.35

155.57

4.3

3.2

g/l

125.2

128.4

4.79

1202

5495

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

854

3266

2.74

152.34

3.1

2.8

u/ml

0.3

0.4

2.24

485

1902

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2984

18642

1.80

151.42

2.0

1.7

mg/l

1.6

1.4

2.52

2442

14326

(3013005) Retinol [Moles/volume] in Serum or Plasma

195

237

8.34

148.46

3.4

1.6

umol/l

2.1

2.0

0.56

183

225

(3018405) Lactate [Moles/volume] in Arterial blood

837

3315

2.64

139.00

6.3

3.9

mmol/l

1.4

0.62

809

3258

(3009261) Glucose [Presence] in Urine by Test strip

5894

44820

1.61

138.88

5.2

3.6

estimate

0.0

2.58

1360

8140

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

517

1578

3.38

136.84

1.5

1.3

—

(3035350) Ketones [Presence] in Urine by Test strip

5821

44235

1.61

136.76

5.1

3.5

estimate

0.0

0.80

1353

8238

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2421

14589

1.82

136.58

2.4

2.0

30.4

29.9

2.03

2345

14156

(3021601) Nitrite [Presence] in Urine by Test strip

5823

44338

1.60

135.04

6.7

4.8

estimate

0.0

0.80

1362

8351

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

986

4293

2.41

133.82

3.7

2.7

1.3

1.2

1.62

977

4271

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1430

7270

2.10

133.08

2.4

2.3

nmol/l

381.7

380.2

0.07

1310

6646

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2415

14651

1.81

132.79

3.8

2.9

e6/l

3.0

2.6

0.80

1385

7906

(3019309) Folate [Moles/volume] in Red Blood Cells

2929

18810

1.73

132.21

2.0

1.8

nmol/l

1203.7

1172.7

0.96

2251

13998

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

4980

36781

1.60

129.44

3.1

2.1

nmol/l

75.8

78.4

7.80

4527

32458

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1912

10862

1.90

129.34

3.7

4.1

u/l

231.6

251.7

8.26

1797

10220

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1061

4840

2.31

129.28

11.2

8.6

mmol/l

24.2

24.3

0.61

1009

4462

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

6999

55994

1.59

129.10

4.6

2.9

u/l

61.2

51.1

9.97

6585

51349

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2853

18292

1.73

129.06

4.4

3.6

ng/l

348.4

513.0

0.78

2282

14970

(3021960) Folate [Moles/volume] in Serum or Plasma

3313

22146

1.68

128.32

1.8

1.5

nmol/l

21.0

20.2

2.47

2881

18739

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

960

4214

2.39

127.75

3.6

2.7

0.7

0.95

937

4015

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2524

15726

1.76

125.91

3.5

2.7

e6/l

1.5

1.3

0.24

1481

8915

(3023520) Reticulocytes [#/volume] in Blood

1506

8044

2.00

121.68

2.6

2.5

e9/l

70.0

68.8

0.59

1110

6107

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

413

1179

3.59

121.14

7.4

5.9

mg/l

12.5

11.8

2.40

377

1065

(3027273) Bicarbonate [Moles/volume] in Venous blood

1004

4648

2.26

117.74

4.8

3.2

mmol/l

25.2

0.12

969

4496

(3047181) Lactate [Moles/volume] in Blood

722

2884

2.60

117.41

8.0

5.5

mmol/l

1.3

0.04

616

2546

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

184

274

6.80

117.25

3.6

1.5

umol/l

27.3

29.1

1.24

179

262

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

5160

39043

1.56

116.97

2.5

2.0

pmol/l

88.8

94.8

17.35

3071

19904

(3009343) pH of Capillary blood

1170

5785

2.13

116.35

4.9

3.6

7.4

1.01

161

784

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1180

5863

2.12

115.84

5.0

3.6

kpa

5.1

5.2

0.49

1096

5409

(3021589) Normoblasts [#/volume] in Blood

5277

40253

1.55

114.57

16.2

9.3

e9/l

0.0

0.15

4432

32762

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1131

5566

2.14

113.74

1.9

1.7

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1137

5609

2.13

113.63

4.8

3.5

mmol/l

1.9

0.17

858

4125

(3007930) Methemoglobin/Hemoglobin.total in Blood

882

3923

2.35

113.50

7.0

4.7

0.9

1.92

824

3679

(40768804) Tissue Pathology biopsy report

4780

35767

1.56

112.53

2.5

2.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

887

3993

2.32

110.94

6.9

4.6

1.6

0.06

829

3742

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

4006

28883

1.58

110.60

2.5

2.1

u/l

226.5

231.0

0.08

3769

26869

(3015736) pH of Urine

4599

34250

1.55

109.82

4.7

3.4

—

5.8

—

(3013707) Erythrocyte sedimentation rate by Westergren method

7958

66971

1.55

106.26

5.0

3.9

mm/h

15.3

13.3

21.01

7375

61273

(3020891) Body temperature

837

3778

2.30

103.85

7.9

4.5

—

(40760892) CBC W Ordered Manual Differential panel - Blood

2786

18643

1.64

103.69

6.2

4.3

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

918

4323

2.21

102.82

5.3

3.9

49.2

47.2

1.53

904

4264

(4035726)

1496

8411

1.89

102.67

1.5

1.4

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

598

2328

2.65

102.23

2.8

2.5

g/l

3.6

0.04

580

2211

(3014765) Yersinia sp identified in Stool by Organism specific culture

537

1985

2.78

101.57

1.3

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

532

1963

2.79

100.96

1.3

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

534

1988

2.76

99.62

1.3

1.1

—

(3017181) Myelocytes/100 leukocytes in Blood

1396

7749

1.91

99.46

4.4

3.9

1.0

0.9

0.57

504

2180

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

10197

91605

1.72

98.05

32.6

13.7

mg/l

31.5

25.3

57.32

9358

72282

(3023183) Ammonium ion [Moles/volume] in Plasma

495

1813

2.80

95.22

2.7

2.5

umol/l

33.2

33.3

0.05

422

1513

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

655

2761

2.45

94.71

2.0

1.6

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

330

957

3.52

94.43

5.3

3.4

nmol/l

12.3

11.8

0.02

322

940

(3022217) INR in Platelet poor plasma by Coagulation assay

2081

13201

1.70

94.03

25.1

27.0

inr

1.4

0.18

315

1698

(3043409) Potassium [Moles/volume] in Arterial blood

668

2864

2.41

93.01

6.9

4.2

mmol/l

3.8

3.9

3.55

617

2678

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

312

882

3.60

92.80

1.6

1.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

874

4207

2.16

92.37

1.8

1.6

g/l

1.7

1.6

2.32

765

3543

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

858

4114

2.17

91.56

7.3

3.6

u/ml

94.8

79.1

0.58

829

3963

(3003181) Sodium [Moles/volume] in Urine

448

1595

2.88

90.82

2.0

1.3

mmol/l

59.0

63.8

1.35

327

1291

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3928

29152

1.51

90.65

3.3

3.0

ng/l

1825.6

1632.6

1.29

3424

25082

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

124

161

7.77

89.34

3.2

3.3

mg/l

6.6

8.0

1.22

127

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

314

914

3.50

89.33

1.6

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

310

895

3.53

89.31

1.6

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

307

884

3.54

88.80

1.6

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

306

884

3.52

88.07

1.6

1.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1663

10083

1.75

88.01

5.2

3.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

305

884

3.51

87.34

1.6

1.4

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2359

15725

1.62

87.04

1.3

1.2

u/ml

1.9

2.0

0.04

622

4204

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2588

17651

1.59

86.76

5.1

3.0

mmol/l

2.5

4.97

2311

15342

(3007164) IgA [Mass/volume] in Serum or Plasma

2135

13908

1.65

86.33

1.5

g/l

2.6

0.06

1357

8277

(3029937) Albumin [Presence] in Urine by Test strip

3377

24548

1.52

84.75

5.7

3.9

estimate

0.0

0.84

1304

7929

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1433

8431

1.79

83.83

2.7

2.3

ug/l

5.2

7.6

8.45

1222

7252

(3039000) Anion gap in Blood

522

2099

2.55

83.33

9.3

6.2

mmol/l

11.0

11.2

0.88

474

1884

(3018572) Chloride [Moles/volume] in Blood

522

2100

2.55

83.25

9.3

6.2

mmol/l

105.3

105.1

0.33

474

1885

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

698

3213

2.24

82.22

2.5

2.2

ug/l

567.8

634.3

0.25

665

3018

(3000494) Fungus identified in Specimen by Culture

1621

9949

1.73

81.67

1.8

1.4

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

4447

34376

1.46

81.48

5.6

3.8

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

171

339

5.10

81.02

16.1

15.6

nmol/l

5814.0

1421.0

0.52

163

330

(3002179) Metamyelocytes/100 leukocytes in Blood

1233

7050

1.83

79.02

4.2

3.7

0.7

0.33

342

1588

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2914

20785

1.53

78.88

1.9

1.7

pmol/l

7512958.0

28582036.2

3.54

2396

16850

(3017143) Hepatitis C virus Ab [Presence] in Serum

1355

7986

1.78

78.49

1.7

1.5

—

(3021440) Promyelocytes/100 leukocytes in Blood

1279

7416

1.81

78.25

4.5

3.9

0.1

0.28

443

2042

(3010421) pH of Blood

578

2509

2.37

78.08

5.1

3.8

7.4

0.22

491

2133

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

162

329

4.97

74.67

12.2

11.0

nmol/l

888.6

827.4

0.71

153

314

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

110

153

7.24

74.65

2.5

2.7

au/ml

182.0

119.4

0.37

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

421

1611

2.67

74.28

6.4

5.3

iu/ml

943.8

1399.9

0.18

235

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

112

161

7.01

73.78

2.9

1.7

mg/l

9.0

9.3

0.21

130

(1616796) Gas panel - Central venous blood

506

2142

2.42

72.25

4.1

3.5

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

514

2194

2.40

72.05

2.9

2.6

211.4

196.0

2.97

496

2092

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

550

2426

2.33

71.55

2.6

2.3

86.7

90.3

2.81

530

2264

(3041096) Erythrocytes [Presence] in Urine by Automated

3184

23529

1.48

71.30

4.9

3.3

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

545

2401

2.33

71.09

3.7

3.1

mmol/l

24.5

24.8

0.88

482

2121

(3003327) Ova and parasites identified in Stool by Light microscopy

481

2009

2.45

70.73

1.7

1.6

—

(3022313) Gas panel - Capillary blood

808

4167

2.01

70.48

5.2

3.7

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

117

8.09

70.20

2.1

1.6

au/ml

151.0

139.0

—

(3025159) Blasts/100 leukocytes in Blood

1184

6939

1.78

69.46

4.6

3.9

0.0

0.4

2.63

381

1722

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1477

9214

1.69

69.26

1.6

1.5

—

(3028626) Oxygen [Partial pressure] in Capillary blood

500

2148

2.38

69.06

4.4

3.2

kpa

8.0

0.14

460

2002

(3012501) Base excess in Blood by calculation

504

2192

2.35

67.69

5.2

3.8

mmol/l

3.1

2.6

2.51

365

1467

(3013290) Carbon dioxide [Partial pressure] in Blood

504

2193

2.35

67.62

5.2

3.8

kpa

5.1

5.0

1.12

491

2133

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

520

2296

2.32

67.45

1.6

iu/ml

6.9

4.1

0.16

107

521

(3027315) Oxygen [Partial pressure] in Blood

505

2206

2.34

67.14

5.2

3.8

kpa

8.7

8.5

1.51

492

2145

(3037121) Protein [Mass/volume] in Urine

635

3053

2.14

66.86

4.6

3.0

g/l

0.3

1.37

394

1244

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1161

6840

1.77

66.77

4.8

3.6

ng/l

104.7

92.1

2.15

995

5777

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

17.73

65.32

1.7

3.1

—

(4281824)

285

959

3.02

63.91

1.2

1.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1643

10768

1.61

62.93

1.8

1.7

—

(3002256) Pathology report gross observation

1788

11983

1.58

62.23

1.4

1.3

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

149

329

4.57

62.15

3.0

1.3

umol/l

17.6

24.8

2.38

144

312

(3024928) Oxygen saturation in Venous blood

428

1807

2.42

61.42

3.1

3.0

—

(3036489) Thrombin time

622

3068

2.08

61.16

2.4

2.0

21.5

21.6

0.16

567

2717

(3052851) Hemolysis interference index of Serum or Plasma

564

2682

2.16

61.02

4.9

3.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

198

547

3.66

61.00

1.4

1.3

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1272

7911

1.68

59.81

2.7

2.5

g/l

65.4

66.3

3.80

1148

7104

(3030981) Hyaline casts [#/volume] in Urine by Automated count

875

4891

1.85

59.68

3.5

2.7

e6/l

0.5

0.3

2.18

857

4768

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

681

3504

2.00

59.59

2.1

1.7

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

724

3816

1.95

59.10

2.2

1.9

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1043

6166

1.76

58.96

2.5

2.8

g/l

10.2

10.7

2.12

947

5609

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

192

535

3.63

58.42

1.4

1.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

391

1656

2.41

55.71

1.7

1.6

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

678

3580

1.95

54.98

5.8

3.9

mmol/l

24.7

24.9

0.89

620

3265

(3028026) IgM [Mass/volume] in Serum or Plasma

837

4786

1.80

52.84

1.9

g/l

1.3

1.4

0.58

766

4298

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

150

381

3.97

52.15

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

150

381

3.97

52.15

1.4

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

133

309

4.34

52.08

3.0

2.6

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

617

3215

1.97

51.97

1.4

1.3

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

390

1708

2.33

51.50

1.7

1.4

pmol/l

209.3

181.6

0.54

376

1663

(3028271) Lactate [Moles/volume] in Capillary blood

361

1530

2.40

51.36

2.3

1.8

mmol/l

1.7

0.08

356

1492

(3021901) Oxygen saturation in Capillary blood

401

1796

2.27

50.24

3.2

2.8

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

5764

49145

1.33

49.52

3.0

2.6

—

(40762365) Oxygen content in Arterial blood by calculation

137

6.16

49.12

3.3

2.9

ml/dl

14.4

14.8

0.46

123

(3011397) Hemoglobin [Presence] in Urine by Test strip

2754

20972

1.40

49.08

4.9

3.6

—

(3019150) Specific gravity of Urine by Refractometry

2584

19482

1.41

48.72

5.6

4.0

kg/l

1.0

1.00

398

2813

(40767503) Oxygen content in Capillary blood by calculation

438

2061

2.17

48.61

2.9

2.5

15.6

16.2

1.42

215

1073

(3013512) EKG study

3507

27878

1.36

47.84

4.8

3.9

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

446

2128

2.14

47.77

1.7

1.5

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

10313

96356

1.47

47.66

36.3

16.3

mmol/l

139.0

139.7

127.48

10140

93567

(3022806) Fractional oxyhemoglobin in Capillary blood

300

1211

2.51

47.45

2.2

1.8

88.8

89.5

1.19

295

1194

(3017315) Amylase [Enzymatic activity/volume] in Urine

141

368

3.86

47.24

1.3

1.2

u/l

296.6

418.9

0.58

134

335

(3051651) Icteric interference index of Serum or Plasma

168

504

3.36

45.71

6.1

3.6

—

(3016038) Potassium [Moles/volume] in Urine

182

575

3.20

45.54

2.1

1.2

mmol/l

32.7

34.8

0.53

159

486

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

431

2068

2.12

45.49

1.7

1.6

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1279

8489

1.57

45.42

3.1

2.8

ng/l

214.4

227.6

0.50

1173

7748

(3023103) Potassium [Moles/volume] in Serum or Plasma

10316

96614

1.46

44.88

36.3

16.5

mmol/l

4.0

15.56

10131

93644

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

324

1390

2.37

44.87

1.3

1.2

—

(40761535) Cells panel - Urine sediment

1177

7763

1.57

42.84

4.6

3.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

131

353

3.74

41.97

1.3

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

130

349

3.75

41.88

1.3

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

599

3316

1.85

41.87

2.6

—

(40761536) Microorganisms panel - Urine sediment

1180

7829

1.56

41.80

5.7

3.8

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

420

2061

2.07

41.78

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

419

2061

2.07

41.41

1.5

1.3

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1240

8376

1.53

40.44

5.1

3.6

mmol/l

1.2

7.57

1114

7184

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

288

1247

2.34

39.09

3.2

2.6

u/ml

1266.7

2609.7

0.59

(3037522) Nuclear Ab [Titer] in Serum

1523

10819

1.47

38.76

1.4

1.3

titre

522.9

528.4

0.04

322

2321

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

224

868

2.61

38.62

3.1

2.7

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

227

893

2.57

37.96

1.4

1.3

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

163

4.99

37.88

2.7

3.0

u/l

1424.1

2645.7

0.46

152

(3006184) Hemoglobin [Mass/volume] in Capillary blood

422

2170

1.98

36.87

2.5

2.2

g/l

125.2

128.1

1.44

334

1592

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

725

4403

1.69

36.70

2.4

—

(3004588) Protein electrophoresis panel - Serum or Plasma

991

6504

1.57

36.63

2.3

—

(3004809) Band form neutrophils/100 leukocytes in Blood

324

1531

2.15

35.61

3.3

1.7

1.4

0.56

253

1170

(3034770) Mitochondria Ab [Titer] in Serum

409

2110

1.97

35.41

1.3

1.2

titre

966.7

957.6

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

328

1569

2.12

34.93

1.7

1.6

—

(3007566) Smooth muscle Ab [Titer] in Serum

407

2108

1.96

34.83

1.3

1.2

titre

114.4

164.7

0.50

185

(3044889) 12 lead EKG panel

7339

66228

1.27

34.71

4.6

3.9

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

269

1194

2.28

34.50

1.5

1.6

g/l

0.7

0.9

1.42

195

887

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

290

1340

2.19

33.74

2.3

2.1

u/l

1898.3

4479.3

1.36

492

(3026250) Tacrolimus [Mass/volume] in Blood

105

285

3.71

33.37

42.9

34.0

ug/l

6.8

7.3

1.50

261

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

325

1579

2.09

33.24

1.6

1.4

—

(3019977) pH of Arterial blood

152

522

2.93

33.05

4.0

2.3

7.4

0.54

199

(3002385) Erythrocyte distribution width [Ratio]

8184

75108

1.28

32.39

37.0

16.9

14.3

13.8

120.52

8059

73205

(36660697) Celiac disease serology panel - Serum

863

5640

1.57

32.38

1.2

1.1

—

(3008295) Osmolality of Serum or Plasma

208

853

2.46

31.93

1.3

1.4

mosm/kgh2o

276.3

279.4

0.89

149

660

(3021879) Hepatitis B virus core Ab [Presence] in Serum

814

5278

1.58

31.59

1.4

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

219

926

2.39

31.44

1.3

1.2

u/l

57.1

64.9

1.04

161

622

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

263

1214

2.19

30.71

1.5

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

287

1374

2.11

30.54

1.5

1.4

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

626

3837

1.67

30.53

1.5

1.6

u/ml

8.3

17.9

1.67

104

(3001186) Copper [Moles/volume] in Serum or Plasma

163

4.50

30.20

1.8

1.2

umol/l

16.3

17.1

0.62

147

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

132

443

3.00

29.94

3.2

3.5

—

(3051611) Lipemic interference index of Serum or Plasma

220

961

2.31

29.35

5.5

3.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

423

2361

1.82

28.77

4.2

3.4

mg/l

1.7

1.6

2.48

394

2125

(3049717) Cytology report of Urine Cyto stain

610

3780

1.65

28.50

2.9

2.8

—

(3010375) cycloSPORINE [Mass/volume] in Blood

108

332

3.27

28.43

25.3

28.0

ug/l

112.3

115.2

0.14

287

(40768441) Liver Pathology biopsy report

160

613

2.63

28.34

1.4

1.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

387

2113

1.86

28.26

1.8

1.6

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

11.62

28.22

1.0

1.1

u/ml

43.2

40.9

—

(3008037) Lactate [Moles/volume] in Venous blood

403

2232

1.83

28.12

4.3

3.1

mmol/l

1.6

1.7

0.87

394

2184

(44790049)

214

942

2.29

28.06

1.8

1.4

—

(44790048)

214

942

2.29

28.06

1.8

1.4

—

(44806118)

214

942

2.29

28.06

1.8

1.4

—

(44790047)

214

942

2.29

28.06

1.8

1.4

—

(3026493) Urate [Moles/volume] in Serum or Plasma

2956

24408

1.28

27.48

3.3

2.6

umol/l

3766.7

5639.1

1.85

2524

20869

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

262

1267

2.09

27.19

1.7

1.5

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

255

1225

2.10

26.94

5.7

4.5

umol/l

354.5

360.0

0.24

228

1021

(3034860) Kappa light chains.free [Mass/volume] in Serum

513

3085

1.69

26.89

3.2

3.3

mg/l

79.2

55.3

1.01

407

2474

(40761511) CBC panel - Blood by Automated count

10035

95206

1.31

26.75

29.3

13.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

512

3082

1.69

26.74

3.2

3.3

mg/l

40.8

47.6

0.89

404

2474

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

234

1092

2.16

26.64

1.3

nmol/l

0.1

0.3

1.89

(3003694) ABO and Rh group [Type] in Blood

2878

23763

1.28

26.61

1.4

1.3

—

(3035637) Corticotropin [Mass/volume] in Plasma

220

1004

2.21

26.48

1.4

1.5

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

497

2992

1.69

25.95

3.1

3.2

ratio

5.2

2.8

0.51

247

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

140

525

2.68

25.92

2.3

1.6

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

7448

68346

1.23

25.87

4.3

3.8

pmol/l

14.9

0.57

6692

61259

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

231

1089

2.14

25.65

1.3

nmol/l

4.2

3.2

0.10

225

1053

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

565

3541

1.62

25.22

2.6

2.2

g/l

7.5

7.4

0.48

398

2617

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

562

3527

1.62

24.95

2.6

2.3

g/l

3.9

3.8

0.38

383

2506

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

563

3537

1.62

24.89

2.6

2.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

490

2989

1.67

24.34

1.7

1.6

titre

378.3

256.2

0.30

130

(3020564) Creatinine [Moles/volume] in Serum or Plasma

10275

98106

1.31

23.90

36.0

16.5

umol/l

82.6

79.8

7.69

10269

98067

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

378

2163

1.77

23.70

1.7

1.5

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

252

1266

2.01

23.63

2.9

2.3

—

(4062490)

173

752

2.32

23.44

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

213

1009

2.13

23.40

3.7

3.8

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

173

754

2.31

23.30

1.3

g/l

0.4

0.44

115

516

(3028192) IgG subclass 2 [Mass/volume] in Serum

173

754

2.31

23.30

1.3

g/l

2.8

3.0

0.56

113

517

(3027135) IgG subclass 1 [Mass/volume] in Serum

173

755

2.31

23.23

1.3

g/l

6.7

7.1

0.36

112

517

(3022493) Free Hemoglobin [Mass/volume] in Plasma

103

349

2.97

23.08

2.8

4.8

mg/l

1483.0

1368.8

0.02

247

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

210

995

2.13

23.06

1.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

525

3307

1.61

22.96

2.6

2.3

g/l

3.2

3.1

1.74

388

2565

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

366

2099

1.77

22.78

1.4

1.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

251

1277

1.99

22.73

1.5

1.4

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

204

963

2.14

22.63

1.3

nmol/l

—

(3052592) Norovirus Ag [Presence] in Stool

184

3.76

22.62

1.6

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

215

1040

2.09

22.38

1.7

1.5

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

522

3315

1.60

22.08

2.6

2.3

g/l

10.2

10.3

0.19

421

2760

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

129

504

2.58

22.07

1.4

1.2

u/l

43.0

23.9

1.75

112

417

(3048929) Epstein Barr virus Ab [Presence] in Serum

342

1942

1.78

22.03

1.2

1.3

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

132

522

2.54

22.03

1.4

1.2

u/l

110.2

86.7

1.35

117

442

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

282

1509

1.89

22.01

1.4

u/ml

20.2

14.5

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

276

3.17

21.85

1.2

1.3

—

(3038515) Glucose [Moles/volume] in Venous blood

365

2124

1.74

21.61

4.5

3.2

mmol/l

7.5

7.8

1.14

357

2083

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

10248

98074

1.29

21.54

17.9

9.9

u/l

25.2

25.9

2.98

9997

93736

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

265

1402

1.91

21.42

1.2

1.3

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

260

1367

1.92

21.42

1.4

u/ml

119.3

122.2

0.10

297

(21494755) Public health laboratory ask at order entry panel

398

6426

0.61

21.10

1.3

1.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

252

1318

1.93

21.09

1.3

u/ml

298.5

273.4

0.53

169

814

(3023419) Bacteria identified in Sputum by Culture

233

1191

1.97

20.86

3.0

2.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

280

1524

1.86

20.75

1.4

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

205

3.48

20.74

1.3

1.2

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

391

2350

1.69

20.59

1.5

1.6

g/l

0.2

0.02

366

2204

(3011985) Renin [Units/volume] in Plasma

217

1087

2.01

20.58

1.5

1.4

mu/l

55.7

63.2

0.18

191

964

(3043410) Blood group antigens tested for on Red Blood Cells

236

3.28

20.48

2.7

1.5

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

156

3.86

20.42

1.3

1.2

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1013

7473

1.39

20.23

4.1

2.7

ml/min/173m2

62.7

62.5

0.05

453

2993

(3037756) Immunofixation for Serum or Plasma

345

2014

1.73

20.22

1.5

1.6

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

158

3.81

20.07

1.3

1.2

—

(3041672) Baker's yeast Ab [Presence] in Serum

10.49

19.98

1.0

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

400

2442

1.66

19.85

1.5

g/l

1.2

0.40

376

2299

(3023487) Leukocytes [#/volume] in Peritoneal fluid

331

2.85

19.72

2.2

1.8

e6/l

1274.7

4577.9

0.63

229

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

343

2.81

19.61

3.1

1.9

umol/l

103.1

124.7

0.44

176

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

188

910

2.08

19.59

1.6

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1174

8918

1.35

19.48

2.0

1.7

1.6

1.5

3.89

984

7730

(3040151) Glucose [Moles/volume] in Capillary blood

219

1123

1.97

19.46

7.6

7.2

mmol/l

7.0

7.6

2.10

197

930

(3011648) Oxygen content in Venous blood

147

648

2.28

19.36

1.9

2.6

10.9

0.08

147

648

(3019225) pH of Specimen

1223

9357

1.34

19.34

5.8

4.0

—

(3044242) Glucose [Moles/volume] in Arterial blood

118

473

2.51

19.21

3.1

1.9

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

152

684

2.24

19.07

1.7

1.6

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

308

1774

1.75

18.95

1.1

u/ml

1.1

10.6

5.34

208

(3003434) Protein [Mass/volume] in Pleural fluid

269

1490

1.82

18.88

1.4

1.5

g/l

31.6

32.2

0.25

244

1316

(3022621) pH of Urine by Test strip

827

5969

1.41

18.75

3.9

2.9

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

394

2432

1.64

18.75

1.6

1.5

iu/ml

6.1

16.3

—

(3023199) Leukocytes [#/volume] in Pleural fluid

243

1313

1.87

18.47

1.5

e6/l

2893.5

2738.9

0.06

171

940

(3044007) Cell count panel - Peritoneal fluid

262

3.03

18.47

1.7

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

205

1051

1.97

18.26

1.1

g/l

1.5

0.34

182

940

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

9108

86438

1.22

18.08

28.5

13.4

ml/min/173m2

77.9

77.1

2.93

8048

70894

(3017354) Segmented neutrophils/100 leukocytes in Blood

185

923

2.02

17.81

3.1

3.3

61.0

58.9

0.60

117

584

(3020961) Endomysium IgA Ab [Titer] in Serum

478

3133

1.55

17.66

1.1

titre

178.3

207.8

—

(3017732) Neutrophils [#/volume] in Blood

826

6027

1.40

17.57

3.9

2.9

e9/l

4.2

4.1

0.31

620

4514

(3024891) Influenza virus A+B Ag [Presence] in Specimen

346

2102

1.66

17.54

1.3

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

489

3233

1.53

17.38

1.1

1.0

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

288

2.86

17.34

2.0

1.7

e6/l

6394.0

12090.5

0.36

160

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

283

2.87

17.29

4.6

2.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

283

2.87

17.29

4.5

2.0

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

127

561

2.28

16.72

1.8

1.5

u/l

5.0

5.4

0.10

257

(3009214) Lutropin [Units/volume] in Serum or Plasma

286

1679

1.72

16.50

1.4

u/l

12.3

10.8

0.94

235

1358

(3033799) Differential panel - Peritoneal fluid

285

2.82

16.50

2.0

1.8

—

(3009542) Hematocrit [Volume Fraction] of Blood

8628

81696

1.19

16.46

31.9

15.1

37.3

39.4

56.89

5397

55174

(3045788) Cell count panel - Pleural fluid

196

1027

1.92

16.42

1.5

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

117

503

2.34

16.41

1.9

2.0

umol/l

11.1

11.6

0.05

362

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

170

849

2.02

16.36

1.6

1.7

—

(3012441) Differential panel - Pleural fluid

214

1157

1.86

16.30

1.5

—

(40760888) Immunoglobulin light chains.free panel - Serum

372

2347

1.60

16.24

3.3

—

(3000475) Leukocytes [#/volume] in Synovial fluid

342

2121

1.63

16.02

1.7

1.6

e6/l

16112.7

14428.0

0.26

243

1522

(3028308) Erythrocytes [#/volume] in Pleural fluid

219

1201

1.84

15.95

1.4

1.5

e6/l

27255.7

51129.9

1.70

130

706

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

195

1032

1.90

15.87

1.3

pmol/l

348.0

276.4

0.46

148

778

(3028707) Methadone [Presence] in Urine by Screen method

160

791

2.04

15.85

3.0

2.5

—

(3026389) Candida sp identified in Specimen by Organism specific culture

214

1168

1.85

15.83

1.4

1.3

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

229

1280

1.80

15.68

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

244

2.92

15.66

1.3

1.2

—

(40757494) Bilirubin.total [Moles/volume] in Blood

113

502

2.26

14.73

3.2

2.2

umol/l

23.2

33.8

0.43

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

149

738

2.03

14.72

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

149

738

2.03

14.72

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

149

738

2.03

14.72

1.6

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

103

3.99

14.72

2.0

1.8

pmol/l

78.4

62.7

0.21

(3017569) Oxygen content in Arterial blood

106

459

2.32

14.68

2.8

2.2

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

292

1783

1.65

14.59

1.2

titre

88.0

193.5

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

226

1288

1.77

14.53

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

135

650

2.09

14.40

1.6

1.3

promille

1.2

1.3

0.19

101

491

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

166

862

1.94

14.35

1.9

1.7

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

449

3041

1.49

14.28

2.4

g/l

0.8

1.1

0.85

386

2562

(3036782) Glucose [Moles/volume] in Pleural fluid

182

980

1.87

14.10

1.3

1.4

mmol/l

6.1

6.4

0.71

167

895

(3006922) Hepatitis E virus Ab [Presence] in Serum

112

507

2.22

13.98

1.1

—

(3045716) Anion gap in Serum or Plasma

102

445

2.30

13.91

1.8

2.3

mmol/l

9.2

9.3

0.05

336

(3042631) Mycobacterium sp identified in Specimen

236

1380

1.72

13.89

2.6

2.7

—

(3005322) IgE [Units/volume] in Serum or Plasma

628

4555

1.40

13.84

1.4

1.3

u/ml

218.3

243.4

0.22

583

4185

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

150

765

1.97

13.69

1.6

1.5

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

450

3076

1.48

13.69

1.2

u/ml

1.7

1.0

0.29

287

(3021788) Differential panel - Synovial fluid

265

1608

1.66

13.60

1.5

—

(3011412) CD3 cells [#/volume] in Blood

150

767

1.97

13.59

2.1

2.4

e9/l

1.1

0.09

493

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

131

638

2.06

13.59

1.3

1.2

titre

120.0

196.8

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

131

638

2.06

13.59

1.3

1.2

titre

155.9

153.1

0.02

105

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

106

475

2.24

13.58

1.1

1.0

—

(3044941) Cell count panel - Synovial fluid

232

1359

1.72

13.58

1.4

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

8752

83435

1.18

13.51

5.2

4.5

mu/l

2.1

2.2

0.59

7887

75211

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

106

477

2.23

13.45

1.1

1.0

—

(3004451) EKG impression Narrative

107

484

2.22

13.41

1.3

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

291

1816

1.62

13.37

1.4

e6/l

8.9

26.8

2.19

232

1410

(3045414) Leukocytes [Presence] in Urine

554

3957

1.42

13.35

2.3

1.9

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

412

2781

1.50

13.34

2.2

g/l

36.6

37.4

1.41

350

2351

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

291

1817

1.62

13.34

1.4

1.5

e6/l

552.1

1300.5

1.73

247

1485

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

396

2652

1.51

13.32

2.4

2.3

g/l

0.0

0.08

363

2401

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

273

1683

1.64

13.18

3.3

3.0

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

274

2.64

13.18

2.0

1.9

u/ml

7319.5

80584.3

0.89

(3006576) Bicarbonate [Moles/volume] in Blood

328

2.48

13.06

5.9

6.0

mmol/l

25.9

24.8

0.93

295

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

193

2.96

12.98

2.0

2.4

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

435

2986

1.47

12.97

1.1

u/ml

1.0

6.9

—

(40768806) Pleura Pathology biopsy report

207

1191

1.75

12.93

1.5

1.6

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

289

1816

1.61

12.92

1.3

mmol/l

3.8

0.41

263

1707

(3032057) Clostridioides difficile [Presence] in Stool

173

3.07

12.86

2.1

1.8

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

123

600

2.06

12.73

1.3

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

446

6317

0.69

12.60

1.7

1.8

—

(3014271) Vancomycin [Susceptibility]

114

543

2.11

12.58

3.6

3.0

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

238

1438

1.67

12.45

1.3

1.4

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

178

991

1.81

12.45

1.3

u/l

524.2

489.3

0.08

165

942

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

393

2670

1.49

12.36

1.7

1.6

—

(1761868) Lipid panel - Serum or Plasma

2658

30171

0.85

12.34

3.0

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1656

13882

1.22

12.21

1.3

1.2

iu/ml

34.4

38.5

0.42

524

4385

(4198724)

222

2.76

12.20

1.4

2.5

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

264

4126

0.63

12.20

1.4

1.5

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

317

2064

1.55

12.18

1.3

1.4

mg/l

513.2

552.9

0.65

298

1952

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

361

2433

1.50

11.83

1.4

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

395

2.26

11.73

1.2

1.1

iu/ml

4.2

4.9

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

364

2465

1.49

11.65

2.3

g/l

0.0

1.01

332

2224

(3000330) Specific gravity of Urine by Test strip

654

4913

1.35

11.62

5.1

3.4

—

(3028717) Thiamine [Mass/volume] in Blood

4.01

11.61

1.3

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

255

1599

1.61

11.55

1.4

1.5

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

106

509

2.09

11.49

2.1

2.6

e6/l

555.0

519.7

0.30

422

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

117

585

2.01

11.38

2.0

2.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

102

486

2.11

11.29

2.2

2.7

e9/l

0.2

0.29

418

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

357

2425

1.49

11.27

2.4

2.3

g/l

0.0

0.00

330

2219

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

129

670

1.93

11.25

1.3

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

422

2.19

11.22

2.5

2.4

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

210

2.72

11.17

1.2

1.1

94.3

86.9

1.03

103

(3044290) Cell count panel - Cerebral spinal fluid

262

1668

1.58

11.15

1.3

1.4

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

156

3.02

11.13

2.9

2.8

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

123

632

1.96

11.08

1.4

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

161

913

1.77

10.66

3.9

3.5

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

204

2.70

10.66

1.2

100.2

87.4

1.59

104

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

213

1307

1.64

10.57

2.1

1.9

ug/l

20.6

22.4

0.30

208

1271

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

231

1447

1.61

10.55

1.3

1.2

—

(4010399)

807

6344

1.29

10.39

1.5

1.4

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

142

782

1.82

10.38

1.3

u/l

15.7

13.1

0.38

131

726

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

463

2.08

10.34

1.2

1.1

u/l

48.2

27.1

0.91

332

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

391

2.18

10.33

1.4

62.2

64.9

0.28

324

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

491

3595

1.38

10.30

1.7

1.8

u/l

39.0

38.8

0.07

427

3097

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

465

2.07

10.23

1.2

1.1

u/l

114.3

89.7

0.70

348

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1451

12208

1.21

10.22

13.9

7.0

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

4.70

10.21

1.1

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

452

2.09

10.21

1.1

1.2

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1543

13068

1.21

10.14

1.3

1.2

u/ml

9.9

14.6

1.96

562

4912

(3027570) Oxalate [Moles/time] in 24 hour Urine

5.27

10.09

1.5

1.3

umol/24h

424.1

296.3

0.87

(3007461) Platelets [#/volume] in Blood

10469

101928

1.20

10.05

45.2

20.4

e9/l

256.4

245.9

38.76

10273

98560

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

145

2.97

9.94

1.2

81.8

72.1

0.43

(3035941) MCH [Entitic mass]

10470

101969

1.20

9.86

45.0

20.3

30.2

30.4

17.67

10336

100002

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

354

2.21

9.82

2.9

2.4

—

(3024731) MCV [Entitic volume]

10470

101980

1.19

9.79

45.0

20.3

91.3

91.4

0.45

10336

100018

(3010813) Leukocytes [#/volume] in Blood

10472

102005

1.19

9.76

45.3

20.4

e9/l

7.1

6.8

36.00

10249

98293

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

4.69

9.74

1.9

3.0

mg/l

2.2

2.4

0.16

(3026361) Erythrocytes [#/volume] in Blood

10470

101988

1.19

9.73

45.2

20.4

e12/l

4.3

4.5

250.59

10239

98274

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

117

620

1.89

9.68

1.5

1.4

—

(3000963) Hemoglobin [Mass/volume] in Blood

10470

102007

1.19

9.61

45.5

20.5

g/l

127.8

134.9

307.65

10339

100043

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1372

11548

1.21

9.60

1.5

1.4

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

209

1311

1.60

9.54

1.8

1.6

—

(1761482) Bacteria [#/volume] in Urine by Culture

380

2704

1.42

9.45

6.2

3.9

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

144

2.92

9.45

1.2

103.0

76.1

1.59

(3042733) HLA Ab [Presence] in Serum

226

2.48

9.22

4.2

4.7

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

221

2.49

9.14

2.0

1.3

g/l

15.9

12.7

1.92

177

(3001893) Eosinophils/100 leukocytes in Pleural fluid

334

2.19

9.05

1.4

1.6

2.8

0.92

283

(3042517) Benzodiazepines panel - Urine

4.57

9.04

2.0

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

103

536

1.93

9.03

2.3

2.6

e6/l

601.7

655.3

0.33

203

(3045424) Erythrocytes [Presence] in Urine

227

1472

1.55

9.01

1.8

1.5

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

114

614

1.86

9.01

1.9

2.1

15.1

14.6

0.13

259

(3021387) Prolactin [Units/volume] in Serum or Plasma

275

1858

1.49

9.01

1.8

1.7

mu/l

351.5

307.1

0.68

254

1692

(3025315) Body weight

4.07

8.95

6.3

3.7

—

(3000093) Morphology [Interpretation] in Blood Narrative

149

878

1.70

8.71

1.2

1.1

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

302

2.22

8.63

1.3

1.4

22.5

20.8

0.20

272

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

102

540

1.90

8.52

1.8

1.9

u/field

2.6

2.9

0.19

373

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

115

3.05

8.51

15.3

10.9

mmol/l

5.0

5.7

0.78

115

(3009508) Creatinine [Moles/volume] in Urine

3301

30032

1.14

8.49

3.4

3.1

mmol/l

7.2

7.4

2.11

2751

24906

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

437

2.00

8.47

1.6

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

437

2.00

8.47

1.6

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

437

2.00

8.47

1.6

1.9

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

350

2507

1.41

8.43

1.5

1.3

iu/l

30.4

33.0

0.67

301

2154

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

438

1.99

8.42

1.6

1.9

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

100

531

1.89

8.29

1.6

1.5

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

641

5040

1.29

8.28

3.1

3.3

pmol/l

4.4

1.11

556

4432

(21494890) Protein electrophoresis panel - 24 hour Urine

162

990

1.64

8.28

1.9

2.0

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

100

534

1.88

8.16

1.6

1.5

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

113

3.01

8.12

4.6

5.5

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

138

815

1.70

8.04

1.3

1.5

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

398

2.02

8.03

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

113

631

1.80

8.01

1.5

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

497

1.90

7.92

3.5

3.8

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

147

887

1.66

7.91

1.1

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

4.86

7.87

1.6

1.5

mg/l

2.4

2.8

0.08

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

4.86

7.87

1.6

1.5

mg/l

2.1

2.5

0.07

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

4.86

7.87

1.6

1.5

mg/l

0.7

1.0

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

4.86

7.87

1.6

1.5

mg/l

1.1

1.8

0.50

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

4.86

7.87

1.6

1.5

mg/l

2.5

3.1

0.12

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

4.86

7.87

1.6

1.5

mg/l

1.3

1.5

0.10

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

4.86

7.87

1.6

1.5

mg/l

0.5

0.9

—

(3013336) Amino acids [Identifier] in Serum or Plasma

15.00

7.70

2.6

3.5

—

(3036071) Salmonella sp Ab [Titer] in Serum

203

2.42

7.69

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

4.50

7.63

1.9

2.6

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

4.73

7.62

1.6

1.5

mg/l

0.8

1.5

0.45

(3011288) Drugs identified in Urine by Screen method

182

1170

1.56

7.58

3.2

2.9

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

135

807

1.68

7.55

1.2

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

203

1339

1.52

7.54

1.3

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

213

1420

1.51

7.52

2.6

2.0

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

452

1.91

7.41

1.3

nmol/l

1.2

0.07

350

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

420

1.93

7.27

1.3

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

420

1.93

7.27

1.3

1.6

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

215

2.33

7.25

1.8

1.3

nmol/l

134.7

128.6

0.09

154

(21494815) CD4 cells/100 lymphocytes in Specimen

117

682

1.72

7.20

1.9

2.3

30.4

40.5

1.29

(3017937) Magnesium [Moles/time] in 24 hour Urine

6.88

7.14

1.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

438

1.90

7.08

1.0

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

315

2.07

7.05

1.5

1.4

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

194

2.38

6.98

1.7

1.4

g/l

31.5

54.8

0.36

152

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

399

1.93

6.94

1.3

1.2

60.7

62.1

—

(3035880) pH of Pleural fluid

101

571

1.77

6.93

1.3

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

204

1373

1.49

6.92

1.2

—

(3020393) Adenovirus Ag [Presence] in Stool

3.05

6.86

1.1

1.3

—

(3016879) Cocaine [Presence] in Urine

245

1713

1.44

6.84

2.7

2.0

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

3.34

6.80

1.7

umol/l

47.6

44.2

0.24

(3010144) Erythrocytes [#/volume] in Synovial fluid

136

839

1.63

6.78

1.4

e6/l

142339.2

144532.8

0.01

558

(3016244) Insulin [Units/volume] in Serum or Plasma

383

1.94

6.71

2.9

3.2

mu/l

20.7

24.0

0.41

362

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

131

803

1.64

6.71

1.2

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

121

2.73

6.67

2.2

2.8

mg/l

106.0

59.4

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

565

1.76

6.60

1.1

1.0

mg/l

292.3

291.0

0.06

512

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

258

2.14

6.52

1.3

1.2

—

(3006270) Folate [Moles/volume] in Blood

132

817

1.62

6.52

1.2

nmol/l

341.2

349.3

0.17

100

660

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

139

872

1.60

6.50

1.5

30.6

28.5

0.28

527

(3012516) Albumin [Mass/volume] in Urine

3149

28971

1.12

6.39

3.5

3.2

mg/l

820.9

354.0

3.82

2124

18198

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

261

2.11

6.35

2.4

2.2

nmol/l

145.9

147.3

0.04

226

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

328

2443

1.35

6.33

1.6

1.7

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

284

2.05

6.18

1.9

2.3

31.3

30.0

0.23

265

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

172

1147

1.51

6.15

1.6

1.5

61.8

60.1

0.21

108

702

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

8734

89802

0.90

6.10

4.5

4.4

mmol/l

1.5

1.09

7878

81579

(21494434) Karyotype in Bone marrow

125

778

1.61

6.07

1.1

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

628

5120

1.24

6.04

1.2

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

117

2.65

5.96

1.3

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

113

690

1.64

5.93

1.1

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

135

861

1.57

5.93

1.9

2.2

u/field

2.2

2.1

0.05

323

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

359

1.90

5.87

1.5

2.0

—

(3020682) Albumin/Creatinine [Ratio] in Urine

3303

30583

1.11

5.86

4.1

3.9

mg/mmol

13.5

9.6

2.64

2139

19185

(3000764) Benzodiazepines [Presence] in Urine

255

1849

1.39

5.86

2.6

1.9

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

353

1.90

5.82

12.7

11.1

mmol/l

0.6

0.16

320

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

116

717

1.62

5.81

2.2

2.4

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.00

5.78

1.3

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

102

2.75

5.77

1.8

2.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

241

1737

1.39

5.75

1.2

1.3

miu/ml

170.5

213.3

1.01

747

(3028300) Cannabinoids [Presence] in Urine

256

1865

1.38

5.73

2.6

1.9

—

(3045142) Bone marrow Pathology biopsy report

155

1028

1.51

5.72

1.3

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

106

643

1.65

5.72

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

276

2037

1.36

5.70

2.7

2.2

—

(3027008) Opiates [Presence] in Urine

255

1859

1.38

5.68

2.6

1.8

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

305

2290

1.34

5.63

1.7

1.9

mg/l

11.6

0.02

272

2121

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

453

1.77

5.55

2.9

2.8

39.1

37.2

0.27

154

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

114

711

1.61

5.53

1.8

1.6

u/ml

26.2

24.1

0.16

153

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

229

2.10

5.51

8.7

7.6

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

354

1.87

5.46

1.5

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

354

1.87

5.46

1.5

2.0

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

561

4573

1.24

5.44

1.9

1.8

—

(3017704) Immunofixation for Urine

493

1.73

5.44

1.9

1.5

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

238

2.06

5.38

1.5

1.2

umol/l

2.7

3.6

1.66

223

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

619

5106

1.22

5.37

2.0

1.8

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

3.72

5.35

5.1

9.0

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

118

2.55

5.35

2.0

1.6

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

444

1.76

5.33

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

101

2.68

5.31

2.1

1.9

umol/l

17.2

18.7

0.27

101

(3023410) Appearance of Cerebral spinal fluid

122

782

1.57

5.29

1.5

1.7

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

247

2.03

5.26

1.5

—

(3027944) Amphetamines [Presence] in Urine

248

1825

1.37

5.25

2.6

1.9

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

108

2.60

5.20

1.8

2.0

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.75

5.08

1.1

1.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

8844

90611

0.91

4.97

4.5

mmol/l

4.5

4.6

36.18

8020

82806

(3044927) Protein electrophoresis panel - Urine

139

932

1.50

4.94

1.2

—

(3002619) Bacteria identified in Specimen by Culture

189

2.12

4.76

1.3

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

126

837

1.51

4.70

1.1

—

11.9

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

164

2.20

4.69

4.6

6.1

u/l

53.1

48.7

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

158

2.22

4.66

1.4

1.5

10.6

10.4

0.01

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

617

1.59

4.64

1.3

titre

23.8

67.6

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

111

720

1.55

4.62

1.1

—

(40768443) Skin Pathology biopsy report

484

3958

1.23

4.61

1.2

—

(3020491) Glucose [Moles/volume] in Blood

100

636

1.58

4.55

1.9

2.1

mmol/l

7.6

7.2

0.54

451

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

161

1131

1.43

4.54

1.2

u/ml

3.8

4.1

0.07

363

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

116

2.42

4.53

1.3

71.0

72.5

0.09

(3016018) Differential panel - Cerebral spinal fluid

129

871

1.49

4.47

1.5

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

105

2.48

4.44

1.1

1.0

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

250

1.92

4.41

1.3

1.2

g/l

0.3

0.52

199

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

162

2.16

4.41

1.2

1.3

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

100

642

1.56

4.38

1.3

titre

95.0

441.9

2.24

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

216

1.99

4.38

2.5

3.1

—

(40768795) Lymph node Pathology biopsy report

139

960

1.45

4.31

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

197

2.03

4.30

9.3

7.6

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

289

2244

1.29

4.30

3.6

3.0

nmol/l

0.8

0.55

229

1758

(3028433) Virus identified in Specimen by Culture

281

1.85

4.29

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

320

2519

1.28

4.28

2.0

1.8

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

155

1096

1.42

4.24

2.4

2.0

mg/l

32.2

28.3

0.33

301

(3038177) Helicobacter pylori Ab [Presence] in Serum

161

1147

1.41

4.23

1.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

286

2224

1.29

4.22

1.3

1.2

u/ml

23.8

38.0

0.68

136

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

174

1257

1.39

4.21

1.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.61

4.19

1.1

1.0

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

267

2060

1.30

4.18

1.3

u/ml

11.8

6.2

0.38

339

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

220

1.96

4.18

1.3

1.1

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

626

1.55

4.18

1.2

1.1

—

37.5

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

201

1491

1.35

4.14

1.2

1.3

u/l

29.1

37.8

0.62

175

1270

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

314

1.79

4.12

2.6

2.9

umol/l

27.4

28.6

0.26

229

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

155

1104

1.41

4.09

1.3

1.2

u/ml

4.0

4.5

0.28

484

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

263

2035

1.30

4.05

1.2

1.3

u/ml

10.3

4.4

0.35

219

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

2.56

4.03

2.9

1.9

mmol/l

1.1

1.4

0.24

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

249

1914

1.31

4.02

1.2

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

273

1.83

4.02

1.3

1.4

pmol/l

15.7

16.4

0.33

225

(3006462) Nitrate [Presence] in Urine

414

1.67

4.01

2.8

3.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

290

2276

1.28

4.00

1.2

1.3

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

136

2.21

4.00

1.2

1.3

ng/l

82.5

177.7

0.92

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

169

2.07

3.99

1.1

1.2

pmol/l

310.9

307.5

0.02

123

(3012898) Urea [Moles/volume] in Urine

2.67

3.97

1.3

mmol/l

165.0

159.0

0.07

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

256

1981

1.30

3.95

2.0

1.8

—

(4306422)

152

1088

1.40

3.91

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

305

1.77

3.90

1.1

1.0

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

224

1706

1.32

3.88

1.2

u/ml

27.8

4.9

0.55

135

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

519

1.58

3.87

1.1

1.2

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

321

1.75

3.85

1.5

1.7

nmol/l

3.3

4.1

0.33

271

(3024263) Appearance of Synovial fluid

489

1.60

3.83

2.0

1.6

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

420

1.65

3.81

1.2

—

(3012565) Volume of 24 hour Urine

459

1.62

3.80

2.0

2.2

1891.5

1909.1

0.03

392

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

148

1062

1.40

3.77

1.1

116.7

0.01

134

946

(3008116) Ketones [Moles/volume] in Urine by Test strip

173

2.03

3.77

1.8

1.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

361

1.69

3.75

1.1

1.0

—

(4268621)

109

742

1.47

3.70

2.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

246

1.83

3.63

1.6

ug/l

10.2

8.8

1.06

246

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.37

3.63

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

116

2.24

3.62

2.3

1.8

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

204

1.91

3.60

1.9

1.4

ug/l

0.5

0.4

0.46

122

(3028679) Herpes simplex virus Ab [Presence] in Serum

343

1.69

3.59

1.2

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

633

1.50

3.59

3.1

2.4

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

9099

92733

0.92

3.56

5.0

mmol/l

2.5

2.7

57.25

8204

84363

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

209

1598

1.31

3.56

1.3

1.2

u/ml

53.0

48.2

0.12

167

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

436

1.61

3.56

1.2

1.1

ratio

1.1

0.26

150

(40757373) Influenza virus identified in Isolate

198

1.92

3.55

1.7

1.6

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

444

1.60

3.55

1.2

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

292

1.75

3.55

1.9

1.8

—

(3036603) Volume of Urine

603

1.51

3.54

1.6

1898.4

1931.4

0.08

154

(3013166) Neutrophils/100 leukocytes in Synovial fluid

285

1.76

3.53

1.3

1.4

57.9

59.4

0.10

238

(3000060) B lymphocytes [#/volume] in Blood

199

1.91

3.51

1.8

2.5

e6/l

942.5

811.6

0.05

104

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

122

859

1.42

3.49

1.0

1.1

u/ml

1.6

3.6

2.66

399

(3019420) Tryptase [Mass/volume] in Serum or Plasma

369

1.66

3.49

1.5

1.7

ug/l

7.3

10.0

0.53

339

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

158

2.03

3.48

1.8

3.3

ng/l

174.7

114.3

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.70

3.48

1.2

1.1

—

(3000492) Spirometry study

869

7671

1.14

3.45

1.5

—

(3051593) INR in Capillary blood by Coagulation assay

487

1.56

3.45

10.1

11.6

—

(21494814) CD8 cells/100 lymphocytes in Specimen

340

1.68

3.44

1.8

1.9

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

310

1.71

3.43

1.2

1.3

ug/l

217.2

183.7

0.10

182

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

115

804

1.43

3.43

1.2

1.4

nmol/l

0.2

0.3

1.02

589

(3000012) Reticulocyte production index

616

1.50

3.42

1.5

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.34

3.39

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

153

2.03

3.38

1.1

1.2

umol/24h

0.8

0.7

0.46

(3012989) Citrate [Moles/time] in 24 hour Urine

5.71

3.33

1.9

1.2

mmol/24h

1.4

2.4

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

306

1.70

3.31

1.1

miu/ml

1720.4

1458.0

0.77

306

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

254

2014

1.27

3.30

1.4

1.3

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

183

1.91

3.27

1.2

—

(4211845)

462

1.56

3.27

2.9

3.3

—

(3036180) Methadone [Presence] in Urine

8.57

3.26

1.7

2.9

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

137

1000

1.37

3.22

1.3

1.2

u/ml

25.6

45.2

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

113

798

1.42

3.22

1.1

91.9

96.0

0.80

106

747

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

151

1120

1.35

3.21

1.1

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

143

2.03

3.19

1.3

1.6

ug/l

68.6

117.9

3.04

122

(3020876) Protein [Mass/time] in 24 hour Urine

114

808

1.41

3.18

1.8

1.9

g/24h

0.9

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

214

1.82

3.16

1.1

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

2.47

3.11

1.3

ml/s/173m2

0.9

1.0

0.20

(44786800) Granulocytes/100 leukocytes in Body fluid

138

2.03

3.09

1.3

27.6

22.6

0.26

108

(40768446) Kidney Pathology biopsy report

305

1.67

3.08

2.0

1.6

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

3.45

3.04

2.8

1.6

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.50

3.03

1.0

1.1

u/l

7.5

14.6

1.00

(40768800) Prostate Pathology biopsy report

171

2221

0.77

3.02

1.2

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

457

1.53

2.98

1.5

1.4

2.1

3.4

0.69

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

226

1.77

2.96

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.54

2.94

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

109

780

1.40

2.92

1.4

1.3

nmol/l

1.4

0.01

697

(3000285) Sodium [Moles/volume] in Blood

128

2.03

2.90

1.2

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

365

1.59

2.90

2.8

2.2

umol/l

67.0

55.8

1.58

294

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

119

866

1.38

2.89

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

118

1604

0.73

2.88

1.8

1.6

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

699

1.42

2.86

1.5

1.2

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

251

1.71

2.86

1.4

1.3

16.7

22.0

0.74

205

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

248

1998

1.25

2.86

1.4

1.7

iu/l

3.6

9.0

0.62

684

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

116

2.07

2.81

1.6

1.4

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

186

1.83

2.81

1.2

mg/l

1.0

58.6

1.00

142

(37021550) Renin [Units/volume] in Plasma --upright

151

1.92

2.78

1.0

1.3

mu/l

170.8

63.9

0.66

114

(3041918) Cholesterol [Moles/volume] in Pleural fluid

187

1.82

2.77

1.3

1.2

mmol/l

1.7

1.5

0.33

112

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

3.23

2.76

1.4

1.5

u/l

0.4

0.1

—

(3008898) HLA-B27 [Presence]

278

2278

1.22

2.76

1.1

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

105

755

1.39

2.75

2.2

1.7

mg/l

4.9

4.1

0.67

714

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.20

2.72

1.2

—

(3046861) Legionella sp Ag [Presence] in Urine

2.59

2.69

1.3

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

139

1.94

2.68

1.0

1.1

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

4.21

2.67

1.4

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

709

0.62

2.64

1.1

1.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

205

1.76

2.63

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.39

2.62

2.7

2.8

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

439

1.51

2.62

1.2

1.6

ug/l

1.6

5.3

2.22

347

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

4.67

2.59

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

244

1.68

2.58

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

222

1.71

2.56

1.0

—

(3007919) Fasciola sp Ab [Titer] in Serum

7.14

2.55

1.0

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

136

1033

1.32

2.54

1.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

193

1.76

2.53

3.0

2.7

mmol/l

7.6

7.9

0.15

113

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

132

1001

1.32

2.50

1.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

3.81

2.46

1.5

1.1

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

2.08

2.42

2.4

3.3

mg/l

0.9

1.3

0.55

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.94

2.41

1.0

1.3

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

6.25

2.37

1.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

220

1.68

2.36

1.1

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

3.64

2.36

1.0

1.1

mmol/l

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.09

2.32

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

452

1.46

2.31

1.4

1.5

u/l

5.5

6.5

0.82

379

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

563

4974

1.14

2.31

1.1

1.2

iu/ml

128.3

142.8

0.35

177

1856

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

469

1.45

2.30

1.1

nmol/l

0.6

6.2

4.02

100

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

105

2.00

2.29

1.7

1.5

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

155

1.81

2.28

5.3

7.0

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

2.07

2.26

1.4

1.2

ug/l

38.6

128.8

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

265

2211

1.20

2.26

5.0

3.3

mg/l

27.4

29.4

0.37

184

1437

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

208

1.68

2.25

2.0

2.9

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

129

995

1.30

2.21

1.3

1.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

211

1726

1.23

2.20

3.7

1.7

nmol/l

0.8

0.30

179

1449

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1837

19520

0.93

2.19

2.8

3.1

ug/l

0.8

0.92

1263

13346

(44813793)

491

1.43

2.18

1.1

—

(4027681)

434

1.45

2.16

1.2

1.3

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

173

1.74

2.15

2.2

1.6

ug/l

2.6

2.4

0.11

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

451

1.44

2.15

1.4

1.6

—

(3049242) von Willebrand panel - Platelet poor plasma

3.68

2.15

1.7

1.6

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

3554

34121

1.06

2.15

4.8

5.0

ug/l

3.2

3.7

0.78

3093

30319

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

322

1.52

2.12

1.1

—

(3014891) Appearance of Pleural fluid

174

1.73

2.12

1.8

1.4

—

(3003338) MCHC [Mass/volume]

7762

76101

1.05

2.10

40.8

18.0

g/l

330.4

332.1

43.96

7678

75382

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.45

2.10

1.1

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

283

3324

0.85

2.05

1.9

1.7

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

269

1.56

2.04

1.4

1.3

14.5

28.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

230

1.61

2.03

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.40

2.02

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

147

1.77

2.01

2.0

1.7

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

700

6325

1.11

2.01

2.5

2.1

nmol/l

12.3

12.4

0.09

605

5569

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

442

1.43

1.99

1.1

iu/ml

6.1

12.1

1.70

(3025018) Bordetella pertussis Ab [Titer] in Serum

402

1.44

1.96

1.3

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

186

1.67

1.96

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

141

1.77

1.95

1.4

1.2

mmol/l

0.3

1.3

1.48

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

241

1.58

1.94

1.0

1.1

—

(3024471) HLA-A [Type]

257

1.56

1.93

1.0

—

(36303858) Crystals [Presence] in Urine

3.53

1.83

1.0

1.2

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

122

1.80

1.83

1.4

1.2

u/l

27.4

584.1

0.87

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

4.17

1.82

1.4

2.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

647

1.33

1.82

1.3

mmol/l

1.9

2.1

2.18

601

(3009871) Measles virus Ab [Titer] in Serum

224

1.56

1.75

1.7

—

(3023420) DNA double strand Ab [Units/volume] in Serum

106

829

1.28

1.71

1.3

1.4

—

21.9

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

1.89

1.64

1.1

1.0

ug/l

101.5

81.3

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

650

1.31

1.64

1.2

1.3

mmol/l

10.7

11.7

0.53

176

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

353

0.59

1.62

1.2

1.4

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

3.57

1.61

1.0

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.84

1.61

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

2.50

1.59

1.0

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

151

1.66

1.59

1.4

1.3

titre

188.8

234.7

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.00

1.58

1.1

1.6

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

206

1.55

1.58

1.6

—

(3019832) Treponema pallidum Ab [Presence] in Serum

470

4220

1.12

1.58

1.6

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.20

1.56

1.0

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

183

1.59

1.56

1.6

1.5

ng/l

163.8

111.8

0.73

183

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

566

0.69

1.56

6.2

6.3

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.85

1.55

1.2

1.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

176

1.59

1.53

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.92

1.53

1.1

1.2

umol/24h

1.9

1.7

0.20

(3036670) Protein [Mass/volume] in Synovial fluid

281

1.46

1.53

1.2

g/l

37.4

40.0

0.47

146

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

536

1.33

1.52

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

209

1.53

1.50

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

8551

86591

0.96

1.49

4.1

4.0

mmol/l

1.3

10.81

7695

77987

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

1.90

1.49

1.8

1.4

nmol/l

0.2

0.1

—

(3024932) HLA-DR beta [Type]

251

1.47

1.46

1.0

1.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.37

1.45

1.1

nmol/l

242.4

254.1

—

(4024509)

114

922

1.24

1.44

1.8

1.5

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

3.12

1.43

1.0

2.0

2.9

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

277

1.44

1.43

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

182

1542

1.18

1.43

3.0

3.7

u/ml

31.3

38.2

0.77

175

1492

(3025130) Human papilloma virus identified in Specimen

106

852

1.25

1.42

1.6

1.7

—

(3030313) Adrenal Ab [Titer] in Serum

2.25

1.40

1.0

1.1

—

(3022475) Manganese [Moles/volume] in Blood

2.17

1.39

1.6

1.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

277

2431

1.14

1.38

2.0

1.7

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

624

1.28

1.38

1.5

1.7

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

190

1.53

1.36

1.0

1.1

—

(3010838) Calcium [Moles/time] in 24 hour Urine

442

1.34

1.36

1.6

mmol/24h

7.4

6.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.78

1.32

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

844

9035

0.93

1.30

1.5

1.6

—

(3008536) Aspergillus sp Ab [Presence] in Serum

169

1.54

1.28

1.6

2.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.08

1.27

1.1

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

539

4942

1.09

1.26

1.3

au/ml

49.7

51.2

0.04

218

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

231

2634

0.87

1.25

1.6

mg/l

3.8

3.5

0.19

155

1859

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

482

0.70

1.25

1.2

1.5

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

476

1.30

1.23

1.5

1.4

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

228

1.45

1.23

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.16

1.21

8.3

3.6

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

213

1.46

1.19

1.1

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.31

1.18

1.0

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

323

1.36

1.18

1.1

99.7

95.4

0.50

247

(3009677) Dengue virus Ab [Presence] in Serum

2.50

1.15

1.0

1.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

403

1.32

1.14

1.1

u/l

1.0

1.1

1.25

192

(1002224) Polysomnography panel

261

2931

0.89

1.14

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.85

1.13

1.6

1.5

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

554

1.26

1.12

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

554

1.26

1.12

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

361

1.33

1.12

1.1

1.0

u/ml

0.9

1.8

0.50

108

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

2.33

1.12

1.0

—

(3020650) Glucose [Presence] in Urine

208

1.44

1.12

1.8

1.4

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

2.00

1.12

1.1

—

(3026470) Cobalt [Mass/volume] in Blood

671

1.24

1.11

2.0

1.9

ug/l

4.9

3.8

0.42

594

(40765096) Chromosome analysis panel by Banding

267

1.39

1.11

1.0

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

555

1.26

1.11

1.1

—

(4212803)

1.70

1.11

1.1

1.0

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

593

5499

1.08

1.10

2.4

au/ml

44.5

25.6

1.11

262

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

104

1.63

1.09

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

559

1.25

1.06

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

559

1.25

1.06

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

559

1.25

1.06

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.92

1.06

1.0

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

2.12

1.05

24.0

10.5

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

1034

0.82

1.05

1.3

1.2

mmol/l

7.3

7.7

0.60

749

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

113

1.59

1.05

1.0

1.2

u/l

25.5

17.6

0.57

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

228

1.40

1.05

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.83

1.02

1.0

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2347

24228

0.96

1.01

1.8

1.6

mmol/l

1.4

1.3

3.66

1954

20000

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.65

1.00

2.8

2.2

—

(3036048) Francisella tularensis Ab [Titer] in Serum

189

1.43

0.98

1.0

1.2

—

532.0

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

240

1.38

0.97

1.5

1.3

28.3

34.8

0.46

158

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

270

2432

1.11

0.97

2.2

2.4

ug/min

185.8

106.3

1.28

160

1439

(40758292) HTLV I+II Ab panel - Serum

117

1.54

0.93

1.2

1.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

606

1.22

0.92

2.6

1.9

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

175

1.43

0.92

1.2

1.1

u/ml

0.3

1.2

1.03

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

562

1.23

0.91

1.1

mg/l

262.4

298.3

1.07

483

(3025577) Chromium [Mass/volume] in Blood

663

1.21

0.90

2.1

2.0

ug/l

2.4

0.01

554

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

193

1.40

0.89

1.1

1.3

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.90

0.88

1.0

1.6

—

(3016750) Collection duration of Urine

565

1.22

0.87

2.1

min

496.8

498.9

0.05

400

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

824

1.18

0.84

1.3

u/l

32.7

30.9

0.22

671

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

542

1.22

0.83

1.4

1.3

u/ml

1.4

1.2

0.10

266

(3034092) Cytoplasmic Ig cells/100 cells in Blood

113

1.50

0.81

19.4

7.8

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

589

1.21

0.81

1.2

mg/l

38.1

44.0

0.91

482

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.57

0.81

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

642

0.81

0.80

1.3

1.5

—

(3013762) Body weight Measured

0.00

0.79

0.0

1.3

—

(21491868) Cryoglobulin [Mass/volume] in Serum

312

1.28

0.78

1.1

1.2

g/l

—

0.3

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.67

0.78

1.1

1.0

—

(4015189)

251

1.32

0.77

2.5

2.0

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

1.59

0.77

1.0

iu/ml

13.4

16.1

—

(3047189) Immunofixation for 24 hour Urine

465

1.23

0.77

1.6

1.7

—

(4034850)

330

3044

1.09

0.77

15.4

10.4

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

132

1.44

0.75

2.5

2.8

u/field

0.8

0.5

0.57

132

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.70

0.75

1.0

—

(3000034) Microalbumin [Mass/volume] in Urine

108

938

1.15

0.74

3.2

3.0

mg/l

38.4

51.9

0.32

684

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.67

0.74

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

158

1.39

0.74

1.1

1.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.64

0.73

1.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

108

1.48

0.73

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

125

1.44

0.72

1.7

1.5

—

(3001729) Color of Synovial fluid

1.55

0.71

1.1

1.6

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

308

1.27

0.71

1.1

u/ml

25.6

7.2

—

(44806420)

310

0.74

0.71

2.2

2.5

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.75

0.71

1.1

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

531

5626

0.94

0.71

1.4

1.3

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

336

1.25

0.69

1.1

ng/l

263.6

592.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.51

0.69

1.0

1.1

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

1.67

0.68

1.0

1.2

—

2.0

—

(3019174) dRVVT (LA screen)

1.53

0.68

1.0

1.3

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

228

2090

1.09

0.65

2.0

1.7

nmol/l

43.1

42.7

0.09

221

2019

(3048879) Bone marrow aspiration report

277

1.26

0.64

1.6

1.8

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

495

1.19

0.64

1.9

2.2

ug/min

116.2

148.0

0.18

118

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.47

0.63

1.2

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.49

0.63

2.8

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.49

0.63

1.8

2.6

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

215

2341

0.92

0.62

1.4

1.3

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.63

0.62

1.0

1.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.67

0.61

1.2

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.59

0.0

1.0

—

(3017509) Phencyclidine [Presence] in Urine

1.54

0.59

1.3

1.6

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.56

0.58

1.2

1.1

—

(40768793) Breast Pathology biopsy report

179

1951

0.92

0.55

1.2

1.3

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.62

0.55

1.0

1.7

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.58

0.54

1.0

1.7

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

249

1.25

0.53

1.8

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

441

1.18

0.53

1.1

—

(40758358) Immune stain study

1.54

0.53

1.0

—

(4146454)

115

1033

1.11

0.53

2.6

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.43

0.52

1.0

1.1

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

269

1.23

0.50

5.0

4.0

72.0

70.4

0.14

217

(40765089) Chromosome analysis panel - Blood by G-banded

118

1.36

0.50

1.0

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

171

1.29

0.49

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

290

0.79

0.48

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

299

1.20

0.47

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

112

1013

1.11

0.47

1.2

1.3

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.62

0.45

1.2

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

759

0.88

0.45

4.1

5.0

u/ml

59.8

106.7

0.78

225

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

136

1247

1.09

0.44

1.1

iu/ml

7278.7

779.7

0.42

284

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

112

1.34

0.44

7.7

5.6

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

112

1.34

0.44

3.9

2.8

—

(3004775) Volume in Urine collected for unspecified duration

811

1.11

0.42

2.0

2.2

732.6

652.7

0.87

529

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

122

1.31

0.42

1.2

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.38

0.42

1.4

1.2

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.43

0.41

1.3

2.8

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.38

0.41

1.4

1.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

573

0.87

0.41

1.2

1.3

pmol/l

93.5

123.2

0.22

174

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.39

0.40

1.1

1.7

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.47

0.40

1.0

mmol/l

7.3

8.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

232

1.21

0.39

1.7

1.8

—

(3044009) aPTT.lupus sensitive (LA screen)

1.31

0.39

1.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

551

1.13

0.38

1.4

1.5

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

945

0.91

0.37

1.1

u/ml

3.8

2.0

0.31

223

(3005011) Chlamydia sp Ab [Titer] in Serum

116

1.29

0.36

1.7

1.6

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

125

1.28

0.36

1.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

714

0.90

0.36

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

713

0.90

0.36

1.4

—

(44806071)

1.33

0.35

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

712

0.90

0.35

1.4

—

(3022689) Creatine [Moles/volume] in Urine

273

1.17

0.34

2.1

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

711

0.90

0.34

1.4

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.37

0.34

2.6

1.9

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

651

1.11

0.34

1.0

ng/l

291.0

337.3

1.09

449

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

584

0.89

0.34

1.4

1.8

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

652

1.10

0.33

1.0

ng/l

36.5

44.1

1.17

440

(3047352) Trisomy 18 risk [Likelihood] in Fetus

594

0.89

0.33

1.5

1.4

—

(3005033) Fetal Nuchal fold Thickness US

591

0.90

0.31

1.5

1.4

—

(3024869) Neuronal Ab [Presence] in Serum

174

1.21

0.31

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

120

1.25

0.30

1.2

1.4

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.27

0.30

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

131

1395

0.94

0.29

1.4

1.5

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

222

1.17

0.29

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

222

1.17

0.29

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

222

1.17

0.29

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

222

1.17

0.29

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

103

1.26

0.28

1.0

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.32

0.28

1.3

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

651

1.09

0.28

1.0

ng/l

785.6

705.6

0.68

428

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

9035

89990

1.01

0.27

4.9

4.7

mmol/l

6.0

0.98

8124

80911

(3014599) Egg white IgE Ab [Units/volume] in Serum

358

1.12

0.25

1.1

u/ml

0.7

1.6

—

(3050794) Legionella sp Ab [Presence] in Serum

1.20

0.25

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

611

0.92

0.24

1.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

104

976

1.07

0.24

1.0

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2704

27299

0.99

0.24

4.2

4.4

21.5

22.3

1.68

1309

13951

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

412

0.90

0.23

5.0

u/ml

26.0

255.6

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.28

0.23

1.0

1.6

—

(4133840)

209

1.15

0.22

1.3

1.2

—

(3027035) Albumin [Mass/time] in 24 hour Urine

1.25

0.22

1.1

1.4

—

692.7

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.27

0.22

3.1

4.6

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

314

1.11

0.22

1.1

1.0

u/ml

0.5

1.9

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.21

0.0

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.21

0.0

1.1

—

2250.8

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

1.16

0.21

4.4

3.8

—

0.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.16

0.21

12.8

8.1

—

(3034426) Prothrombin time (PT)

258

1.12

0.21

1.1

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

126

1.19

0.21

1.2

1.1

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

6.9

—

0.3

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.20

0.0

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

176

0.85

0.20

1.2

1.4

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

336

1.10

0.19

1.2

1.3

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

442

1.09

0.19

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

103

977

1.05

0.19

1.0

1.1

—

(3009015) Lactate [Moles/volume] in Synovial fluid

100

1.20

0.18

1.2

mmol/l

5.8

6.8

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.19

0.18

1.0

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.17

0.17

1.0

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

8606

85810

1.01

0.16

6.5

5.9

mmol/mol

40.4

40.3

0.55

7863

78329

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

770

0.95

0.15

1.4

1.5

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.10

0.15

1.2

1.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

816

0.96

0.13

1.0

1.1

u/ml

4.6

3.7

0.17

314

(3037556) Urate [Mass/volume] in Serum or Plasma

303

0.92

0.12

1.3

1.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

406

1.06

0.11

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1151

11594

0.99

0.09

4.5

4.6

33.6

32.7

1.90

779

7613

(4094501)

226

2302

0.98

0.09

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

115

1178

0.98

0.08

1.1

u/ml

1.1

1.2

0.08

459

(3039744) RNA polymerase III Ab [Units/volume] in Serum

0.81

0.07

1.0

1.1

—

4.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

306

0.95

0.07

1.2

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

108

1056

1.02

0.06

1.1

u/ml

2.8

4.3

0.62

519

(3041806) Other cells [#/volume] in Blood by Manual count

105

0.86

0.06

1.0

1.4

—

(3015183) Erythrocyte sedimentation rate

325

1.05

0.06

1.0

1.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

139

1.08

0.05

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

208

1.06

0.05

3.0

6.8

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

110

1.09

0.05

1.5

1.6

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

189

1.06

0.04

1.2

1.3

—

(3050129) First trimester maternal screen panel - Serum or Plasma

876

0.98

0.04

1.3

1.4

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

745

0.98

0.04

1.0

1.1

u/ml

4.9

3.6

0.21

287

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1107

11098

1.00

0.03

1.5

1.4

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

168

0.95

0.02

1.1

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

192

1933

0.99

0.02

1.4

1.5

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

680

0.98

0.02

1.0

u/ml

2.9

0.5

0.39

148

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

147

0.95

0.01

1.3

2.8

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

133

1.05

0.01

1.1

1.4

72.6

52.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

173

1.04

0.01

1.1

1.2

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

247

0.97

0.01

1.4

1.5

mmol/l

8.2

8.3

0.08

149

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

194

1.03

0.00

1.1

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

115

1.04

0.00

1.0

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

115

1.04

0.00

1.0

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

115

1.04

0.00

1.0

1.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

102

1018

1.00

0.00

1.1

u/ml

2.7

1.1

0.35

423

(3035933) Granulocytes/100 leukocytes in Blood

186

1.02

0.00

1.4

1.3

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

125

0.96

0.00

1.0

1.2

—

(3011897) Casein IgE Ab [Units/volume] in Serum

0.94

0.00

1.0

1.2

—

0.5

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

0.00

0.0

1.0

—

268.0

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

8.0

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.92

0.00

1.0

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

0.0

1.0

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.99

0.00

1.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.86

0.00

4.8

5.5

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.99

0.00

1.3

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

127.8

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

31.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

0.0

1.3

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

0.0

1.0

—

0.5

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint K11_ILEUS and mortality.

Females

Parameter	HR [95% CI]	p-value
K11_ILEUS	2.51 [2.28, 2.77]	< 0.001
Birth year	0.993 [0.99, 1.0]	0.101

During the follow-up period (1.1.1998 — 31.12.2019), 15397 out of 34140 females with K11_ILEUS died.

Males

Parameter	HR [95% CI]	p-value
K11_ILEUS	2.46 [2.2, 2.75]	< 0.001
Birth year	0.985 [0.98, 0.99]	0.001

During the follow-up period (1.1.1998 — 31.12.2019), 14525 out of 31020 males with K11_ILEUS died.

Mortality risk

Mortality risk for people of age

years, who have K11_ILEUS.

N-year risk	Females	Males
1	0.267%	0.525%
5	1.3%	2.784%
10	3.286%	6.393%
15	6.189%	11.797%
20	10.969%	19.532%

Relationships between endpoints

↥

Index endpoint: K11_ILEUS – Paralytic ileus and intestinal obstruction

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Paralytic ileus and intestinal obstruction

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints